# pathway_nodes

date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - RANIBIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - RANIBIZUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £20,117
first_seen: 2021-05-26
last_seen: 2024-10-03
first_seen_parent: 2021-04-03
last_seen_parent: 2025-04-22
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RANIBIZUMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 26 times with a 2.7 weekly interval (70.2 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 12 times with a 9.6 weekly interval (115.2 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 285.4, "avg_administrations": 29}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 325.5, "avg_administrations": 12}]


date_filter_id: 1yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £10,372
first_seen: 2021-04-23
last_seen: 2025-07-01
first_seen_parent: 2019-09-25
last_seen_parent: 2025-09-08
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 363.1, "avg_administrations": 8}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 19 times with a 11.9 weekly interval (226.1 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £6,515
first_seen: 2019-01-20
last_seen: 2025-04-04
first_seen_parent: 2020-05-14
last_seen_parent: 2024-04-06
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 303.9, "avg_administrations": 28}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 27 times with a 2.2 weekly interval (59.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £7,566
first_seen: 2021-09-03
last_seen: 2024-12-02
first_seen_parent: 2017-09-24
last_seen_parent: 2025-05-09
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 185.8, "avg_administrations": 18}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9 times with a 5.8 weekly interval (52.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £6,480
first_seen: 2020-06-20
last_seen: 2024-09-09
first_seen_parent: 2017-06-05
last_seen_parent: 2025-04-27
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 206.6, "avg_administrations": 18}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 12 times with a 3.0 weekly interval (36.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £14,144
first_seen: 2021-07-03
last_seen: 2025-08-19
first_seen_parent: 2018-03-26
last_seen_parent: 2024-08-07
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 351.6, "avg_administrations": 26}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 8 times with a 9.3 weekly interval (74.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £24,179
first_seen: 2020-10-05
last_seen: 2024-09-30
first_seen_parent: 2018-05-03
last_seen_parent: 2025-08-26
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 443.7, "avg_administrations": 23}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 15 times with a 9.5 weekly interval (142.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £15,243
first_seen: 2021-05-20
last_seen: 2025-11-11
first_seen_parent: 2019-02-07
last_seen_parent: 2024-02-09
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 19 times with a 7.4 weekly interval (140.6 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 24 times with a 7.7 weekly interval (184.8 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 170.0, "avg_administrations": 23}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 321.2, "avg_administrations": 5}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £7,419
first_seen: 2020-04-04
last_seen: 2025-04-29
first_seen_parent: 2018-05-18
last_seen_parent: 2025-02-17
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 25 times with a 10.1 weekly interval (252.5 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 20 times with a 3.9 weekly interval (78.0 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 363.2, "avg_administrations": 5}, {"drug": "ETANERCEPT", "avg_dose_mg": 110.9, "avg_administrations": 30}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £20,890
first_seen: 2020-10-17
last_seen: 2025-09-16
first_seen_parent: 2019-01-10
last_seen_parent: 2024-03-06
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 332.0, "avg_administrations": 9}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 28 times with a 3.7 weekly interval (103.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - RITUXIMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £9,795
first_seen: 2020-10-10
last_seen: 2024-02-27
first_seen_parent: 2019-04-26
last_seen_parent: 2025-09-23
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 22 times with a 4.6 weekly interval (101.2 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 18 times with a 2.7 weekly interval (48.6 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 230.7, "avg_administrations": 5}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 193.5, "avg_administrations": 24}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £11,785
first_seen: 2020-01-23
last_seen: 2024-07-01
first_seen_parent: 2020-12-23
last_seen_parent: 2024-10-14
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 72.1, "avg_administrations": 14}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 21 times with a 4.5 weekly interval (94.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £11,379
first_seen: 2019-01-12
last_seen: 2024-08-11
first_seen_parent: 2017-05-17
last_seen_parent: 2024-02-17
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 397.1, "avg_administrations": 12}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 10 times with a 9.9 weekly interval (99.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £11,734
first_seen: 2021-09-16
last_seen: 2024-09-06
first_seen_parent: 2018-06-04
last_seen_parent: 2025-12-28
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 319.5, "avg_administrations": 15}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 9 times with a 10.0 weekly interval (90.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £14,057
first_seen: 2019-04-08
last_seen: 2025-01-01
first_seen_parent: 2017-07-29
last_seen_parent: 2024-05-15
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 56.0, "avg_administrations": 24}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 26 times with a 8.2 weekly interval (213.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - TRASTUZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - TRASTUZUMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £19,711
first_seen: 2019-03-11
last_seen: 2024-04-13
first_seen_parent: 2021-01-10
last_seen_parent: 2024-05-12
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 17 times with a 5.3 weekly interval (90.1 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 9 times with a 6.2 weekly interval (55.8 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 365.6, "avg_administrations": 24}, {"drug": "BARICITINIB", "avg_dose_mg": 277.0, "avg_administrations": 10}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £15,432
first_seen: 2018-12-10
last_seen: 2025-01-03
first_seen_parent: 2017-04-07
last_seen_parent: 2025-07-08
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 493.3, "avg_administrations": 26}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 19 times with a 2.5 weekly interval (47.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £8,484
first_seen: 2019-04-09
last_seen: 2025-11-12
first_seen_parent: 2020-01-23
last_seen_parent: 2024-06-13
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 214.4, "avg_administrations": 13}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 7 times with a 6.7 weekly interval (46.9 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - BEVACIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - BEVACIZUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £3,861
first_seen: 2022-11-09
last_seen: 2025-09-14
first_seen_parent: 2019-09-13
last_seen_parent: 2024-08-08
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 25 times with a 8.3 weekly interval (207.5 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 15 times with a 3.5 weekly interval (52.5 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 310.1, "avg_administrations": 28}, {"drug": "INFLIXIMAB", "avg_dose_mg": 450.7, "avg_administrations": 11}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - BEVACIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - BEVACIZUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £11,691
first_seen: 2022-08-08
last_seen: 2025-08-04
first_seen_parent: 2020-06-28
last_seen_parent: 2024-01-30
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 5 times with a 7.8 weekly interval (39.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 11 times with a 10.0 weekly interval (110.0 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 204.4, "avg_administrations": 10}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 70.9, "avg_administrations": 23}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £23,954
first_seen: 2018-11-23
last_seen: 2025-02-13
first_seen_parent: 2018-06-18
last_seen_parent: 2024-10-02
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 130.4, "avg_administrations": 14}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 11 times with a 11.8 weekly interval (129.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £19,742
first_seen: 2020-01-13
last_seen: 2025-11-21
first_seen_parent: 2020-08-22
last_seen_parent: 2024-07-13
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 464.9, "avg_administrations": 7}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 21 times with a 11.0 weekly interval (231.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - AFLIBERCEPT - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £10,689
first_seen: 2019-03-18
last_seen: 2025-12-23
first_seen_parent: 2020-07-04
last_seen_parent: 2024-09-17
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 21 times with a 10.1 weekly interval (212.1 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 23 times with a 4.2 weekly interval (96.6 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 285.3, "avg_administrations": 5}, {"drug": "NIVOLUMAB", "avg_dose_mg": 477.9, "avg_administrations": 13}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £22,531
first_seen: 2020-09-24
last_seen: 2024-11-13
first_seen_parent: 2017-08-20
last_seen_parent: 2024-09-25
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 98.2, "avg_administrations": 10}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 8 times with a 6.4 weekly interval (51.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY - SECUKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY - SECUKINUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £2,671
first_seen: 2019-09-15
last_seen: 2025-12-20
first_seen_parent: 2020-12-20
last_seen_parent: 2025-02-04
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 18 times with a 4.7 weekly interval (84.6 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 26 times with a 6.5 weekly interval (169.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 241.6, "avg_administrations": 24}, {"drug": "NIVOLUMAB", "avg_dose_mg": 266.5, "avg_administrations": 18}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £3,356
first_seen: 2021-06-19
last_seen: 2025-01-26
first_seen_parent: 2020-07-12
last_seen_parent: 2024-10-11
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 409.1, "avg_administrations": 19}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 19 times with a 8.5 weekly interval (161.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY - TOFACITINIB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY - TOFACITINIB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £5,767
first_seen: 2020-07-30
last_seen: 2025-07-27
first_seen_parent: 2020-01-22
last_seen_parent: 2025-08-31
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOFACITINIB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 9 times with a 3.7 weekly interval (33.3 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 13 times with a 9.5 weekly interval (123.5 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 316.3, "avg_administrations": 20}, {"drug": "BARICITINIB", "avg_dose_mg": 67.5, "avg_administrations": 12}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £20,426
first_seen: 2020-04-11
last_seen: 2024-12-09
first_seen_parent: 2019-06-11
last_seen_parent: 2024-03-23
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 53.6, "avg_administrations": 11}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 23 times with a 5.8 weekly interval (133.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £6,744
first_seen: 2018-04-24
last_seen: 2025-08-27
first_seen_parent: 2019-10-03
last_seen_parent: 2024-10-28
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 310.3, "avg_administrations": 11}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: RHEUMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 25 times with a 4.2 weekly interval (105.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - BARICITINIB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - BARICITINIB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £7,690
first_seen: 2021-02-23
last_seen: 2024-03-22
first_seen_parent: 2018-05-07
last_seen_parent: 2025-07-02
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: BARICITINIB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 18 times with a 10.4 weekly interval (187.2 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 24 times with a 4.7 weekly interval (112.8 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 234.4, "avg_administrations": 15}, {"drug": "IBRUTINIB", "avg_dose_mg": 357.1, "avg_administrations": 11}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - BARICITINIB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - BARICITINIB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £7,676
first_seen: 2020-02-12
last_seen: 2024-11-21
first_seen_parent: 2019-06-21
last_seen_parent: 2024-04-19
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: BARICITINIB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 23 times with a 6.2 weekly interval (142.6 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 30 times with a 7.9 weekly interval (237.0 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 204.2, "avg_administrations": 9}, {"drug": "RITUXIMAB", "avg_dose_mg": 65.1, "avg_administrations": 6}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £10,140
first_seen: 2019-11-09
last_seen: 2024-12-27
first_seen_parent: 2017-02-15
last_seen_parent: 2024-07-14
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 430.3, "avg_administrations": 14}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 5 times with a 2.3 weekly interval (11.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £23,554
first_seen: 2018-07-19
last_seen: 2025-03-22
first_seen_parent: 2020-05-01
last_seen_parent: 2025-09-01
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 432.3, "avg_administrations": 18}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 9 times with a 6.6 weekly interval (59.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ADALIMUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £20,910
first_seen: 2019-12-11
last_seen: 2024-05-18
first_seen_parent: 2019-12-05
last_seen_parent: 2025-05-12
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9 times with a 11.0 weekly interval (99.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 17 times with a 6.8 weekly interval (115.6 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 362.0, "avg_administrations": 17}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 144.8, "avg_administrations": 27}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £7,051
first_seen: 2021-10-21
last_seen: 2025-04-06
first_seen_parent: 2019-04-02
last_seen_parent: 2025-09-26
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 273.7, "avg_administrations": 4}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 28 times with a 5.9 weekly interval (165.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £14,587
first_seen: 2021-12-18
last_seen: 2024-07-25
first_seen_parent: 2020-06-02
last_seen_parent: 2025-06-17
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 181.7, "avg_administrations": 18}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 25 times with a 7.7 weekly interval (192.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ETANERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ETANERCEPT - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £17,376
first_seen: 2022-03-19
last_seen: 2025-10-18
first_seen_parent: 2020-12-20
last_seen_parent: 2025-06-25
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ETANERCEPT|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 27 times with a 11.5 weekly interval (310.5 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 29 times with a 4.8 weekly interval (139.2 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 457.7, "avg_administrations": 29}, {"drug": "NIVOLUMAB", "avg_dose_mg": 189.0, "avg_administrations": 4}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ETANERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ETANERCEPT - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £19,092
first_seen: 2019-03-12
last_seen: 2025-06-13
first_seen_parent: 2019-02-03
last_seen_parent: 2025-10-02
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ETANERCEPT|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 26 times with a 2.6 weekly interval (67.6 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 18 times with a 4.6 weekly interval (82.8 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 308.4, "avg_administrations": 30}, {"drug": "USTEKINUMAB", "avg_dose_mg": 162.7, "avg_administrations": 13}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £8,153
first_seen: 2020-04-28
last_seen: 2025-05-22
first_seen_parent: 2017-10-21
last_seen_parent: 2025-01-07
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 425.9, "avg_administrations": 12}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 27 times with a 9.9 weekly interval (267.3 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £22,416
first_seen: 2022-02-05
last_seen: 2025-03-21
first_seen_parent: 2021-10-14
last_seen_parent: 2025-08-23
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 23 times with a 6.3 weekly interval (144.9 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 6 times with a 5.9 weekly interval (35.4 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 284.6, "avg_administrations": 27}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 264.5, "avg_administrations": 27}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £23,572
first_seen: 2021-01-11
last_seen: 2025-01-27
first_seen_parent: 2017-05-26
last_seen_parent: 2025-06-03
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 98.2, "avg_administrations": 6}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 23 times with a 10.1 weekly interval (232.3 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £10,212
first_seen: 2019-04-01
last_seen: 2025-04-19
first_seen_parent: 2019-06-04
last_seen_parent: 2024-04-17
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 351.0, "avg_administrations": 12}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 13 times with a 6.3 weekly interval (81.9 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - INFLIXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - INFLIXIMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £11,173
first_seen: 2022-11-12
last_seen: 2024-03-05
first_seen_parent: 2021-01-13
last_seen_parent: 2025-12-22
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 19 times with a 8.8 weekly interval (167.2 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 7 times with a 11.6 weekly interval (81.2 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 93.6, "avg_administrations": 10}, {"drug": "ETANERCEPT", "avg_dose_mg": 221.0, "avg_administrations": 18}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - RITUXIMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £7,399
first_seen: 2020-03-04
last_seen: 2025-07-08
first_seen_parent: 2019-06-19
last_seen_parent: 2024-09-04
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 10 times with a 7.6 weekly interval (76.0 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 26 times with a 6.2 weekly interval (161.2 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 323.7, "avg_administrations": 15}, {"drug": "NIVOLUMAB", "avg_dose_mg": 116.0, "avg_administrations": 19}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £4,227
first_seen: 2020-09-17
last_seen: 2024-08-04
first_seen_parent: 2019-01-22
last_seen_parent: 2025-01-13
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 475.8, "avg_administrations": 7}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 25 times with a 9.4 weekly interval (235.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £3,540
first_seen: 2019-02-28
last_seen: 2024-07-26
first_seen_parent: 2017-02-14
last_seen_parent: 2025-07-09
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 242.5, "avg_administrations": 16}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 24 times with a 11.0 weekly interval (264.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £14,157
first_seen: 2021-04-19
last_seen: 2025-12-07
first_seen_parent: 2020-04-12
last_seen_parent: 2025-07-18
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 29 times with a 11.3 weekly interval (327.7 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 28 times with a 8.0 weekly interval (224.0 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 327.7, "avg_administrations": 26}, {"drug": "ADALIMUMAB", "avg_dose_mg": 75.7, "avg_administrations": 6}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £11,625
first_seen: 2019-09-11
last_seen: 2024-12-31
first_seen_parent: 2019-03-10
last_seen_parent: 2024-05-07
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 142.5, "avg_administrations": 21}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 28 times with a 8.1 weekly interval (226.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £3,673
first_seen: 2018-06-05
last_seen: 2025-02-14
first_seen_parent: 2020-02-01
last_seen_parent: 2024-04-12
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 243.2, "avg_administrations": 28}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 13 times with a 6.0 weekly interval (78.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £10,591
first_seen: 2020-08-13
last_seen: 2025-11-03
first_seen_parent: 2020-02-22
last_seen_parent: 2025-11-13
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 208.7, "avg_administrations": 7}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 18 times with a 4.6 weekly interval (82.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £9,569
first_seen: 2019-12-17
last_seen: 2025-04-10
first_seen_parent: 2018-01-08
last_seen_parent: 2024-01-27
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 475.4, "avg_administrations": 9}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 26 times with a 6.5 weekly interval (169.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £9,958
first_seen: 2020-11-18
last_seen: 2025-09-23
first_seen_parent: 2019-02-02
last_seen_parent: 2024-04-13
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 211.8, "avg_administrations": 24}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: ONCOLOGY
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 17 times with a 4.1 weekly interval (69.7 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - TRASTUZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - TRASTUZUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £14,237
first_seen: 2021-04-30
last_seen: 2025-03-04
first_seen_parent: 2020-04-26
last_seen_parent: 2024-12-19
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 24 times with a 10.5 weekly interval (252.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 25 times with a 9.5 weekly interval (237.5 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 205.9, "avg_administrations": 13}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 330.7, "avg_administrations": 22}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £18,237
first_seen: 2018-08-24
last_seen: 2024-11-02
first_seen_parent: 2018-05-25
last_seen_parent: 2025-10-30
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 395.6, "avg_administrations": 8}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 27 times with a 8.3 weekly interval (224.1 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £5,418
first_seen: 2019-01-19
last_seen: 2024-02-09
first_seen_parent: 2020-08-09
last_seen_parent: 2025-07-28
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 249.1, "avg_administrations": 23}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 22 times with a 6.2 weekly interval (136.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £22,489
first_seen: 2018-01-08
last_seen: 2025-07-28
first_seen_parent: 2019-10-02
last_seen_parent: 2024-03-21
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 158.9, "avg_administrations": 6}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 18 times with a 2.0 weekly interval (36.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £16,105
first_seen: 2018-10-16
last_seen: 2025-07-01
first_seen_parent: 2017-01-23
last_seen_parent: 2024-04-08
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 285.5, "avg_administrations": 28}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 5 times with a 11.4 weekly interval (57.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £25,991
first_seen: 2021-07-18
last_seen: 2025-02-06
first_seen_parent: 2018-11-12
last_seen_parent: 2024-04-11
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 477.0, "avg_administrations": 8}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 25 times with a 10.6 weekly interval (265.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £3,915
first_seen: 2019-08-23
last_seen: 2025-04-21
first_seen_parent: 2019-04-08
last_seen_parent: 2025-07-04
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 340.5, "avg_administrations": 15}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 25 times with a 4.3 weekly interval (107.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £4,332
first_seen: 2018-02-25
last_seen: 2025-11-10
first_seen_parent: 2019-11-07
last_seen_parent: 2025-08-13
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 385.2, "avg_administrations": 8}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 29 times with a 2.6 weekly interval (75.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £19,986
first_seen: 2019-01-28
last_seen: 2025-09-16
first_seen_parent: 2020-03-26
last_seen_parent: 2025-09-21
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 180.8, "avg_administrations": 22}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 11 times with a 3.9 weekly interval (42.9 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £27,211
first_seen: 2021-03-10
last_seen: 2024-07-22
first_seen_parent: 2017-09-29
last_seen_parent: 2024-02-09
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 261.5, "avg_administrations": 8}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 21 times with a 10.2 weekly interval (214.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - ETANERCEPT
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - ETANERCEPT - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £18,932
first_seen: 2021-03-02
last_seen: 2024-11-21
first_seen_parent: 2018-04-13
last_seen_parent: 2025-08-03
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: ETANERCEPT|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 23 times with a 10.0 weekly interval (230.0 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 4 times with a 9.4 weekly interval (37.6 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 326.5, "avg_administrations": 4}, {"drug": "BARICITINIB", "avg_dose_mg": 227.2, "avg_administrations": 26}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - ETANERCEPT
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - ETANERCEPT - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £18,441
first_seen: 2022-01-29
last_seen: 2025-12-01
first_seen_parent: 2020-09-03
last_seen_parent: 2024-12-03
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: ETANERCEPT|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 16 times with a 11.5 weekly interval (184.0 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 23 times with a 9.1 weekly interval (209.3 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 97.9, "avg_administrations": 26}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 138.4, "avg_administrations": 12}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £17,988
first_seen: 2019-09-27
last_seen: 2025-06-27
first_seen_parent: 2020-05-25
last_seen_parent: 2025-03-29
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 105.0, "avg_administrations": 20}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 18 times with a 2.1 weekly interval (37.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - ADALIMUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £7,513
first_seen: 2019-11-11
last_seen: 2024-02-02
first_seen_parent: 2020-07-04
last_seen_parent: 2024-12-10
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 14 times with a 2.7 weekly interval (37.8 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 10 times with a 2.9 weekly interval (29.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 99.1, "avg_administrations": 5}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 177.1, "avg_administrations": 15}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - ADALIMUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £3,351
first_seen: 2022-01-29
last_seen: 2025-05-11
first_seen_parent: 2021-05-24
last_seen_parent: 2025-05-15
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11 times with a 11.9 weekly interval (130.9 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 6 times with a 5.7 weekly interval (34.2 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 156.9, "avg_administrations": 4}, {"drug": "SECUKINUMAB", "avg_dose_mg": 100.6, "avg_administrations": 21}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £9,147
first_seen: 2020-09-18
last_seen: 2025-11-12
first_seen_parent: 2017-05-02
last_seen_parent: 2024-01-29
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 98.2, "avg_administrations": 20}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8 times with a 9.6 weekly interval (76.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £22,491
first_seen: 2018-02-20
last_seen: 2024-03-22
first_seen_parent: 2020-08-18
last_seen_parent: 2025-04-22
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 70.5, "avg_administrations": 14}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 4 times with a 10.7 weekly interval (42.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - USTEKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - USTEKINUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £16,989
first_seen: 2021-10-28
last_seen: 2025-01-24
first_seen_parent: 2018-11-16
last_seen_parent: 2024-02-19
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 16 times with a 5.8 weekly interval (92.8 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 28 times with a 9.7 weekly interval (271.6 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 305.2, "avg_administrations": 30}, {"drug": "IBRUTINIB", "avg_dose_mg": 180.8, "avg_administrations": 29}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £9,443
first_seen: 2020-10-12
last_seen: 2024-07-03
first_seen_parent: 2020-02-06
last_seen_parent: 2024-02-22
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 278.5, "avg_administrations": 17}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 25 times with a 8.9 weekly interval (222.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - BARICITINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - BARICITINIB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £5,046
first_seen: 2021-09-18
last_seen: 2024-10-17
first_seen_parent: 2021-05-27
last_seen_parent: 2025-05-29
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: BARICITINIB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 11 times with a 7.1 weekly interval (78.1 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 22 times with a 5.9 weekly interval (129.8 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 341.4, "avg_administrations": 15}, {"drug": "IBRUTINIB", "avg_dose_mg": 472.7, "avg_administrations": 28}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £11,187
first_seen: 2018-11-30
last_seen: 2024-11-01
first_seen_parent: 2020-02-13
last_seen_parent: 2025-01-08
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 360.8, "avg_administrations": 22}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 20 times with a 4.1 weekly interval (82.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - USTEKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - USTEKINUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £13,287
first_seen: 2020-06-01
last_seen: 2024-08-12
first_seen_parent: 2021-02-17
last_seen_parent: 2024-07-25
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 28 times with a 2.4 weekly interval (67.2 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 30 times with a 11.0 weekly interval (330.0 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 214.9, "avg_administrations": 10}, {"drug": "SECUKINUMAB", "avg_dose_mg": 257.5, "avg_administrations": 12}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £23,011
first_seen: 2018-02-03
last_seen: 2024-06-29
first_seen_parent: 2017-04-02
last_seen_parent: 2025-12-05
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 138.9, "avg_administrations": 7}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 5 times with a 3.7 weekly interval (18.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £27,525
first_seen: 2018-04-03
last_seen: 2025-03-04
first_seen_parent: 2019-03-07
last_seen_parent: 2025-02-15
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 349.7, "avg_administrations": 24}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 24 times with a 11.1 weekly interval (266.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - TOFACITINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - TOFACITINIB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £4,437
first_seen: 2022-07-08
last_seen: 2024-11-16
first_seen_parent: 2019-02-08
last_seen_parent: 2025-11-22
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 13 times with a 4.7 weekly interval (61.1 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 10 times with a 7.4 weekly interval (74.0 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 129.6, "avg_administrations": 13}, {"drug": "INFLIXIMAB", "avg_dose_mg": 424.3, "avg_administrations": 15}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £8,016
first_seen: 2021-07-08
last_seen: 2025-10-29
first_seen_parent: 2017-12-23
last_seen_parent: 2024-11-03
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 225.3, "avg_administrations": 9}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 15 times with a 11.1 weekly interval (166.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £20,156
first_seen: 2020-08-21
last_seen: 2024-04-20
first_seen_parent: 2020-10-14
last_seen_parent: 2024-03-04
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 351.2, "avg_administrations": 27}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5 times with a 8.9 weekly interval (44.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £10,006
first_seen: 2020-06-02
last_seen: 2025-07-22
first_seen_parent: 2019-09-13
last_seen_parent: 2025-03-05
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 336.7, "avg_administrations": 21}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 18 times with a 6.1 weekly interval (109.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - IBRUTINIB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £17,472
first_seen: 2020-05-08
last_seen: 2024-04-21
first_seen_parent: 2018-09-05
last_seen_parent: 2024-11-14
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 8 times with a 5.6 weekly interval (44.8 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 5 times with a 2.7 weekly interval (13.5 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 485.0, "avg_administrations": 29}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 490.5, "avg_administrations": 27}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - IBRUTINIB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £12,132
first_seen: 2022-01-16
last_seen: 2025-08-09
first_seen_parent: 2018-05-13
last_seen_parent: 2024-08-31
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 12 times with a 9.2 weekly interval (110.4 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 21 times with a 2.6 weekly interval (54.6 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 399.6, "avg_administrations": 9}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 172.5, "avg_administrations": 29}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £17,437
first_seen: 2018-12-22
last_seen: 2024-11-12
first_seen_parent: 2020-05-14
last_seen_parent: 2025-12-28
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 176.4, "avg_administrations": 9}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 11 times with a 3.1 weekly interval (34.1 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £19,195
first_seen: 2021-09-05
last_seen: 2025-07-06
first_seen_parent: 2020-12-17
last_seen_parent: 2024-10-16
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 79.3, "avg_administrations": 19}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 26 times with a 7.6 weekly interval (197.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - OCRELIZUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £15,691
first_seen: 2019-05-04
last_seen: 2025-05-08
first_seen_parent: 2020-11-27
last_seen_parent: 2025-02-22
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 29 times with a 10.5 weekly interval (304.5 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 28 times with a 11.2 weekly interval (313.6 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 440.4, "avg_administrations": 14}, {"drug": "NIVOLUMAB", "avg_dose_mg": 259.1, "avg_administrations": 27}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - OCRELIZUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £12,476
first_seen: 2019-10-11
last_seen: 2025-07-21
first_seen_parent: 2018-04-16
last_seen_parent: 2024-12-02
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 8 times with a 6.9 weekly interval (55.2 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 16 times with a 5.3 weekly interval (84.8 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 393.7, "avg_administrations": 11}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 96.3, "avg_administrations": 18}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £19,063
first_seen: 2020-08-10
last_seen: 2025-06-09
first_seen_parent: 2017-03-22
last_seen_parent: 2024-12-05
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 377.1, "avg_administrations": 7}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 8 times with a 7.1 weekly interval (56.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - NATALIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - NATALIZUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £19,363
first_seen: 2020-02-21
last_seen: 2024-04-21
first_seen_parent: 2019-02-11
last_seen_parent: 2025-12-07
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 10 times with a 4.9 weekly interval (49.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 14 times with a 4.2 weekly interval (58.8 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 50.8, "avg_administrations": 27}, {"drug": "USTEKINUMAB", "avg_dose_mg": 448.9, "avg_administrations": 13}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - NATALIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - NATALIZUMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £12,095
first_seen: 2019-05-22
last_seen: 2025-12-02
first_seen_parent: 2021-01-09
last_seen_parent: 2024-04-17
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 27 times with a 2.9 weekly interval (78.3 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 16 times with a 5.2 weekly interval (83.2 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 222.0, "avg_administrations": 22}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 316.0, "avg_administrations": 25}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £7,958
first_seen: 2021-12-04
last_seen: 2024-01-16
first_seen_parent: 2018-02-25
last_seen_parent: 2025-07-16
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 123.1, "avg_administrations": 23}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 12 times with a 10.4 weekly interval (124.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - BEVACIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - BEVACIZUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £16,838
first_seen: 2021-11-29
last_seen: 2024-09-13
first_seen_parent: 2020-06-12
last_seen_parent: 2024-07-20
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 9 times with a 6.0 weekly interval (54.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 5 times with a 11.8 weekly interval (59.0 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 217.3, "avg_administrations": 13}, {"drug": "TOFACITINIB", "avg_dose_mg": 174.8, "avg_administrations": 11}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - BEVACIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - BEVACIZUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £11,339
first_seen: 2022-01-14
last_seen: 2025-03-17
first_seen_parent: 2019-05-02
last_seen_parent: 2024-12-27
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 9 times with a 2.0 weekly interval (18.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 8 times with a 6.1 weekly interval (48.8 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 254.5, "avg_administrations": 9}, {"drug": "USTEKINUMAB", "avg_dose_mg": 170.9, "avg_administrations": 4}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £5,700
first_seen: 2019-09-19
last_seen: 2025-08-23
first_seen_parent: 2018-02-11
last_seen_parent: 2025-01-21
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 291.6, "avg_administrations": 26}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 26 times with a 9.3 weekly interval (241.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - TRASTUZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - TRASTUZUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £12,447
first_seen: 2021-08-08
last_seen: 2025-02-21
first_seen_parent: 2020-05-26
last_seen_parent: 2024-02-14
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 23 times with a 2.1 weekly interval (48.3 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 28 times with a 11.7 weekly interval (327.6 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 389.7, "avg_administrations": 27}, {"drug": "RITUXIMAB", "avg_dose_mg": 280.0, "avg_administrations": 7}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - TRASTUZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - TRASTUZUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £6,333
first_seen: 2019-07-06
last_seen: 2025-05-16
first_seen_parent: 2020-08-16
last_seen_parent: 2025-04-26
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 6 times with a 11.3 weekly interval (67.8 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 11 times with a 5.2 weekly interval (57.2 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 431.4, "avg_administrations": 26}, {"drug": "TOFACITINIB", "avg_dose_mg": 165.4, "avg_administrations": 18}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £13,438
first_seen: 2021-09-15
last_seen: 2024-05-08
first_seen_parent: 2017-07-06
last_seen_parent: 2024-11-09
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 199.7, "avg_administrations": 10}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 4 times with a 12.0 weekly interval (48.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £6,362
first_seen: 2019-03-15
last_seen: 2025-07-26
first_seen_parent: 2020-02-15
last_seen_parent: 2024-03-30
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 308.2, "avg_administrations": 28}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 7 times with a 3.1 weekly interval (21.7 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £9,515
first_seen: 2020-10-06
last_seen: 2024-12-15
first_seen_parent: 2019-10-07
last_seen_parent: 2025-10-11
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 389.7, "avg_administrations": 12}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 26 times with a 9.1 weekly interval (236.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £18,033
first_seen: 2018-01-15
last_seen: 2025-09-12
first_seen_parent: 2020-10-23
last_seen_parent: 2025-09-06
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 325.0, "avg_administrations": 4}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 6 times with a 8.9 weekly interval (53.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £11,451
first_seen: 2019-02-16
last_seen: 2024-05-05
first_seen_parent: 2017-08-30
last_seen_parent: 2024-06-15
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 83.3, "avg_administrations": 24}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 15 times with a 12.0 weekly interval (180.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - TOCILIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - TOCILIZUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £3,946
first_seen: 2021-04-14
last_seen: 2025-07-04
first_seen_parent: 2021-04-26
last_seen_parent: 2024-06-30
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 24 times with a 11.3 weekly interval (271.2 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 9 times with a 6.7 weekly interval (60.3 weeks total treatment length)

average_administered:
[{"drug": "TOCILIZUMAB", "avg_dose_mg": 427.7, "avg_administrations": 7}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 272.2, "avg_administrations": 23}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £14,953
first_seen: 2021-12-28
last_seen: 2025-09-06
first_seen_parent: 2019-05-19
last_seen_parent: 2025-05-06
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 145.3, "avg_administrations": 12}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 23 times with a 9.7 weekly interval (223.1 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - RITUXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - RITUXIMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £10,840
first_seen: 2020-08-07
last_seen: 2024-04-17
first_seen_parent: 2019-01-19
last_seen_parent: 2024-10-14
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 18 times with a 11.4 weekly interval (205.2 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 29 times with a 7.2 weekly interval (208.8 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 76.1, "avg_administrations": 10}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 325.3, "avg_administrations": 18}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - RITUXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - RITUXIMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £17,434
first_seen: 2021-12-24
last_seen: 2025-06-16
first_seen_parent: 2021-12-26
last_seen_parent: 2024-07-03
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 6 times with a 11.8 weekly interval (70.8 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 17 times with a 9.1 weekly interval (154.7 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 315.1, "avg_administrations": 6}, {"drug": "ETANERCEPT", "avg_dose_mg": 137.0, "avg_administrations": 28}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £13,645
first_seen: 2021-05-16
last_seen: 2024-08-14
first_seen_parent: 2020-03-21
last_seen_parent: 2025-02-16
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 349.6, "avg_administrations": 10}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 6 times with a 8.9 weekly interval (53.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £10,303
first_seen: 2020-03-21
last_seen: 2025-03-23
first_seen_parent: 2018-04-18
last_seen_parent: 2025-10-15
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 202.0, "avg_administrations": 29}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 27 times with a 11.8 weekly interval (318.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - USTEKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - USTEKINUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £6,882
first_seen: 2019-03-30
last_seen: 2024-03-12
first_seen_parent: 2021-01-24
last_seen_parent: 2025-01-31
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 18 times with a 4.5 weekly interval (81.0 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 15 times with a 2.9 weekly interval (43.5 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 438.6, "avg_administrations": 8}, {"drug": "NATALIZUMAB", "avg_dose_mg": 393.1, "avg_administrations": 17}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £22,012
first_seen: 2020-02-19
last_seen: 2024-03-04
first_seen_parent: 2019-12-02
last_seen_parent: 2025-02-05
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 407.1, "avg_administrations": 16}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 27 times with a 11.2 weekly interval (302.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - ADALIMUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - ADALIMUMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £8,027
first_seen: 2019-09-13
last_seen: 2025-11-05
first_seen_parent: 2020-03-18
last_seen_parent: 2025-08-19
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 26 times with a 4.3 weekly interval (111.8 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 20 times with a 4.0 weekly interval (80.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 372.3, "avg_administrations": 24}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 391.6, "avg_administrations": 12}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £14,227
first_seen: 2019-02-10
last_seen: 2025-01-25
first_seen_parent: 2020-03-30
last_seen_parent: 2025-11-10
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 394.5, "avg_administrations": 30}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11 times with a 9.9 weekly interval (108.9 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - BARICITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - BARICITINIB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £3,345
first_seen: 2021-03-24
last_seen: 2025-06-20
first_seen_parent: 2020-06-20
last_seen_parent: 2025-11-16
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: BARICITINIB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 13 times with a 9.3 weekly interval (120.9 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 24 times with a 2.3 weekly interval (55.2 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 442.5, "avg_administrations": 8}, {"drug": "IBRUTINIB", "avg_dose_mg": 266.8, "avg_administrations": 4}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - BARICITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - BARICITINIB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £6,916
first_seen: 2020-06-16
last_seen: 2025-10-28
first_seen_parent: 2018-12-04
last_seen_parent: 2024-08-21
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: BARICITINIB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 20 times with a 11.0 weekly interval (220.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 5 times with a 10.8 weekly interval (54.0 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 436.6, "avg_administrations": 12}, {"drug": "TOFACITINIB", "avg_dose_mg": 228.9, "avg_administrations": 6}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £12,418
first_seen: 2020-03-20
last_seen: 2025-10-10
first_seen_parent: 2019-06-24
last_seen_parent: 2024-03-04
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 225.1, "avg_administrations": 26}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 7 times with a 2.8 weekly interval (19.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £25,687
first_seen: 2019-07-13
last_seen: 2025-06-16
first_seen_parent: 2018-01-28
last_seen_parent: 2024-08-09
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 393.1, "avg_administrations": 12}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 7 times with a 4.4 weekly interval (30.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £3,530
first_seen: 2019-09-07
last_seen: 2024-04-05
first_seen_parent: 2017-04-19
last_seen_parent: 2025-02-14
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 328.4, "avg_administrations": 19}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 10 times with a 6.0 weekly interval (60.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - USTEKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - USTEKINUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £12,950
first_seen: 2022-07-08
last_seen: 2025-02-10
first_seen_parent: 2021-08-10
last_seen_parent: 2025-09-12
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 21 times with a 6.2 weekly interval (130.2 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 9 times with a 6.1 weekly interval (54.9 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 480.2, "avg_administrations": 13}, {"drug": "TOFACITINIB", "avg_dose_mg": 229.3, "avg_administrations": 23}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £5,688
first_seen: 2021-01-27
last_seen: 2024-07-12
first_seen_parent: 2018-09-18
last_seen_parent: 2025-03-23
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 116.3, "avg_administrations": 19}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 13 times with a 9.9 weekly interval (128.7 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £26,907
first_seen: 2018-01-09
last_seen: 2024-12-05
first_seen_parent: 2018-01-19
last_seen_parent: 2024-03-15
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 322.4, "avg_administrations": 6}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 16 times with a 7.8 weekly interval (124.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £21,412
first_seen: 2021-03-20
last_seen: 2025-11-26
first_seen_parent: 2019-02-07
last_seen_parent: 2024-07-13
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 321.5, "avg_administrations": 5}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 6 times with a 8.1 weekly interval (48.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - RITUXIMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £18,194
first_seen: 2022-01-24
last_seen: 2024-06-19
first_seen_parent: 2020-07-26
last_seen_parent: 2024-02-03
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 15 times with a 11.6 weekly interval (174.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 28 times with a 7.3 weekly interval (204.4 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 135.5, "avg_administrations": 21}, {"drug": "SECUKINUMAB", "avg_dose_mg": 398.5, "avg_administrations": 16}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £12,118
first_seen: 2018-09-19
last_seen: 2025-06-08
first_seen_parent: 2017-08-05
last_seen_parent: 2024-09-09
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 399.1, "avg_administrations": 20}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 12 times with a 4.0 weekly interval (48.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - IBRUTINIB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £11,583
first_seen: 2022-06-08
last_seen: 2024-02-05
first_seen_parent: 2020-05-09
last_seen_parent: 2024-08-16
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 23 times with a 9.3 weekly interval (213.9 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 29 times with a 4.4 weekly interval (127.6 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 450.4, "avg_administrations": 24}, {"drug": "ADALIMUMAB", "avg_dose_mg": 321.4, "avg_administrations": 15}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - IBRUTINIB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £9,500
first_seen: 2020-03-06
last_seen: 2025-06-12
first_seen_parent: 2020-03-08
last_seen_parent: 2024-11-28
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 22 times with a 8.1 weekly interval (178.2 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 13 times with a 2.6 weekly interval (33.8 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 62.1, "avg_administrations": 12}, {"drug": "NATALIZUMAB", "avg_dose_mg": 220.3, "avg_administrations": 4}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £5,562
first_seen: 2020-11-05
last_seen: 2025-05-04
first_seen_parent: 2018-07-17
last_seen_parent: 2024-02-16
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 158.6, "avg_administrations": 27}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 17 times with a 11.3 weekly interval (192.1 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £14,529
first_seen: 2022-04-06
last_seen: 2025-09-17
first_seen_parent: 2018-04-02
last_seen_parent: 2024-01-02
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 11 times with a 7.3 weekly interval (80.3 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 25 times with a 4.7 weekly interval (117.5 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 465.4, "avg_administrations": 15}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 205.4, "avg_administrations": 5}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £6,419
first_seen: 2019-03-11
last_seen: 2025-05-05
first_seen_parent: 2018-12-28
last_seen_parent: 2025-12-09
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 16 times with a 8.2 weekly interval (131.2 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 25 times with a 8.6 weekly interval (215.0 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 170.2, "avg_administrations": 29}, {"drug": "BARICITINIB", "avg_dose_mg": 188.6, "avg_administrations": 21}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £20,138
first_seen: 2021-03-11
last_seen: 2024-02-11
first_seen_parent: 2017-01-28
last_seen_parent: 2024-09-18
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 421.6, "avg_administrations": 16}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 25 times with a 9.3 weekly interval (232.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £25,507
first_seen: 2021-05-24
last_seen: 2024-06-24
first_seen_parent: 2017-07-11
last_seen_parent: 2024-05-13
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 106.8, "avg_administrations": 27}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 20 times with a 3.5 weekly interval (70.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £12,618
first_seen: 2018-09-05
last_seen: 2024-04-04
first_seen_parent: 2019-09-22
last_seen_parent: 2024-04-13
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 227.0, "avg_administrations": 10}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 24 times with a 11.3 weekly interval (271.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - NIVOLUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - NIVOLUMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £8,370
first_seen: 2022-01-07
last_seen: 2024-10-01
first_seen_parent: 2019-05-23
last_seen_parent: 2024-10-20
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: ONCOLOGY
drug_sequence: NIVOLUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 10 times with a 2.9 weekly interval (29.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 27 times with a 9.0 weekly interval (243.0 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 57.1, "avg_administrations": 26}, {"drug": "ADALIMUMAB", "avg_dose_mg": 262.7, "avg_administrations": 11}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - NIVOLUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - NIVOLUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £16,772
first_seen: 2019-03-30
last_seen: 2024-07-11
first_seen_parent: 2018-03-18
last_seen_parent: 2024-03-02
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: ONCOLOGY
drug_sequence: NIVOLUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 25 times with a 7.4 weekly interval (185.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 20 times with a 5.6 weekly interval (112.0 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 92.6, "avg_administrations": 21}, {"drug": "INFLIXIMAB", "avg_dose_mg": 438.4, "avg_administrations": 29}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £15,618
first_seen: 2019-06-21
last_seen: 2025-07-04
first_seen_parent: 2020-01-26
last_seen_parent: 2025-08-05
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 365.4, "avg_administrations": 13}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: ONCOLOGY
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 7 times with a 7.2 weekly interval (50.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £20,986
first_seen: 2021-12-05
last_seen: 2024-07-01
first_seen_parent: 2018-07-20
last_seen_parent: 2024-12-10
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 160.1, "avg_administrations": 4}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 16 times with a 9.3 weekly interval (148.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £5,182
first_seen: 2021-04-09
last_seen: 2025-11-11
first_seen_parent: 2017-01-11
last_seen_parent: 2024-12-04
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 332.3, "avg_administrations": 27}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 20 times with a 9.8 weekly interval (196.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £26,299
first_seen: 2018-07-08
last_seen: 2024-11-21
first_seen_parent: 2020-03-03
last_seen_parent: 2025-01-01
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 78.8, "avg_administrations": 20}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 27 times with a 9.1 weekly interval (245.7 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £3,856
first_seen: 2021-08-13
last_seen: 2025-05-19
first_seen_parent: 2020-05-19
last_seen_parent: 2025-12-18
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 199.4, "avg_administrations": 8}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 26 times with a 9.7 weekly interval (252.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £20,380
first_seen: 2019-03-29
last_seen: 2025-11-02
first_seen_parent: 2020-12-13
last_seen_parent: 2025-11-17
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 204.5, "avg_administrations": 25}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 27 times with a 8.3 weekly interval (224.1 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £8,899
first_seen: 2018-12-08
last_seen: 2025-09-10
first_seen_parent: 2019-06-01
last_seen_parent: 2025-12-13
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 161.5, "avg_administrations": 22}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 12 times with a 9.3 weekly interval (111.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £14,615
first_seen: 2021-02-05
last_seen: 2024-12-24
first_seen_parent: 2020-07-23
last_seen_parent: 2025-08-13
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 124.1, "avg_administrations": 13}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 26 times with a 6.2 weekly interval (161.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £15,499
first_seen: 2020-02-21
last_seen: 2025-10-13
first_seen_parent: 2020-01-27
last_seen_parent: 2025-12-01
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 295.5, "avg_administrations": 28}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 23 times with a 8.0 weekly interval (184.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - BARICITINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - BARICITINIB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £17,581
first_seen: 2021-07-29
last_seen: 2025-09-19
first_seen_parent: 2018-11-25
last_seen_parent: 2025-02-22
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: BARICITINIB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 19 times with a 3.1 weekly interval (58.9 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 13 times with a 11.7 weekly interval (152.1 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 135.5, "avg_administrations": 20}, {"drug": "INFLIXIMAB", "avg_dose_mg": 394.5, "avg_administrations": 9}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - BARICITINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - BARICITINIB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £14,562
first_seen: 2019-08-13
last_seen: 2024-08-22
first_seen_parent: 2020-12-12
last_seen_parent: 2024-09-19
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: BARICITINIB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 26 times with a 5.0 weekly interval (130.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 14 times with a 9.6 weekly interval (134.4 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 97.4, "avg_administrations": 12}, {"drug": "TOFACITINIB", "avg_dose_mg": 258.8, "avg_administrations": 28}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £18,591
first_seen: 2018-10-04
last_seen: 2025-05-21
first_seen_parent: 2017-04-10
last_seen_parent: 2025-11-30
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 358.0, "avg_administrations": 17}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 4 times with a 4.1 weekly interval (16.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - USTEKINUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - USTEKINUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £11,723
first_seen: 2019-11-18
last_seen: 2024-01-26
first_seen_parent: 2020-04-13
last_seen_parent: 2025-11-21
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 25 times with a 7.5 weekly interval (187.5 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 30 times with a 2.6 weekly interval (78.0 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 384.8, "avg_administrations": 29}, {"drug": "ETANERCEPT", "avg_dose_mg": 274.9, "avg_administrations": 26}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - USTEKINUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - USTEKINUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £7,373
first_seen: 2019-09-03
last_seen: 2025-12-24
first_seen_parent: 2021-10-07
last_seen_parent: 2025-10-04
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 9 times with a 7.9 weekly interval (71.1 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 7 times with a 7.0 weekly interval (49.0 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 436.0, "avg_administrations": 29}, {"drug": "NIVOLUMAB", "avg_dose_mg": 115.4, "avg_administrations": 19}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £7,284
first_seen: 2019-06-21
last_seen: 2025-03-07
first_seen_parent: 2018-09-05
last_seen_parent: 2024-12-23
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 335.0, "avg_administrations": 30}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 16 times with a 4.4 weekly interval (70.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - ADALIMUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - ADALIMUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £3,260
first_seen: 2021-04-06
last_seen: 2024-08-26
first_seen_parent: 2019-11-21
last_seen_parent: 2025-09-21
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 21 times with a 4.0 weekly interval (84.0 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 30 times with a 4.5 weekly interval (135.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 148.2, "avg_administrations": 27}, {"drug": "NATALIZUMAB", "avg_dose_mg": 485.3, "avg_administrations": 15}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £9,892
first_seen: 2021-10-07
last_seen: 2024-11-30
first_seen_parent: 2018-07-20
last_seen_parent: 2024-04-07
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 308.8, "avg_administrations": 5}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5 times with a 10.2 weekly interval (51.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £9,145
first_seen: 2020-10-05
last_seen: 2024-01-25
first_seen_parent: 2018-08-14
last_seen_parent: 2024-10-26
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 485.3, "avg_administrations": 11}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 18 times with a 4.5 weekly interval (81.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £4,006
first_seen: 2018-02-27
last_seen: 2025-12-07
first_seen_parent: 2020-08-07
last_seen_parent: 2024-12-15
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 154.2, "avg_administrations": 25}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 23 times with a 2.3 weekly interval (52.9 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - USTEKINUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - USTEKINUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £9,197
first_seen: 2022-03-19
last_seen: 2024-09-05
first_seen_parent: 2021-04-13
last_seen_parent: 2024-04-14
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 18 times with a 6.0 weekly interval (108.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 22 times with a 10.4 weekly interval (228.8 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 51.8, "avg_administrations": 9}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 379.7, "avg_administrations": 14}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - USTEKINUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - USTEKINUMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £9,004
first_seen: 2020-02-11
last_seen: 2024-04-19
first_seen_parent: 2019-03-28
last_seen_parent: 2024-06-12
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 18 times with a 2.8 weekly interval (50.4 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 30 times with a 6.2 weekly interval (186.0 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 378.0, "avg_administrations": 22}, {"drug": "BARICITINIB", "avg_dose_mg": 313.7, "avg_administrations": 6}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £13,624
first_seen: 2020-01-18
last_seen: 2025-02-20
first_seen_parent: 2020-04-14
last_seen_parent: 2024-05-20
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 256.8, "avg_administrations": 6}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 25 times with a 9.9 weekly interval (247.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £5,799
first_seen: 2021-01-30
last_seen: 2024-09-07
first_seen_parent: 2020-07-07
last_seen_parent: 2025-04-04
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 73.4, "avg_administrations": 9}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 7 times with a 10.3 weekly interval (72.1 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £8,331
first_seen: 2020-06-17
last_seen: 2024-07-30
first_seen_parent: 2018-05-17
last_seen_parent: 2025-02-04
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 52.1, "avg_administrations": 25}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 10 times with a 11.8 weekly interval (118.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £24,044
first_seen: 2018-11-21
last_seen: 2024-08-04
first_seen_parent: 2020-10-01
last_seen_parent: 2025-09-14
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 120.3, "avg_administrations": 7}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 25 times with a 7.5 weekly interval (187.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £25,548
first_seen: 2018-10-30
last_seen: 2025-06-20
first_seen_parent: 2020-01-12
last_seen_parent: 2025-11-20
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 426.9, "avg_administrations": 12}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 11 times with a 6.0 weekly interval (66.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - NATALIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - NATALIZUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £18,559
first_seen: 2019-11-06
last_seen: 2024-08-14
first_seen_parent: 2019-08-14
last_seen_parent: 2024-09-26
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 10 times with a 5.6 weekly interval (56.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 19 times with a 11.3 weekly interval (214.7 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 260.3, "avg_administrations": 16}, {"drug": "SECUKINUMAB", "avg_dose_mg": 98.8, "avg_administrations": 25}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - NATALIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - NATALIZUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £12,979
first_seen: 2021-02-19
last_seen: 2025-02-19
first_seen_parent: 2021-02-05
last_seen_parent: 2024-08-07
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 26 times with a 3.1 weekly interval (80.6 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 5 times with a 11.2 weekly interval (56.0 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 345.3, "avg_administrations": 25}, {"drug": "ETANERCEPT", "avg_dose_mg": 459.5, "avg_administrations": 6}]


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £16,561
first_seen: 2018-10-23
last_seen: 2024-12-25
first_seen_parent: 2018-07-18
last_seen_parent: 2025-06-28
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 105.2, "avg_administrations": 4}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 25 times with a 11.2 weekly interval (280.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £7,956
first_seen: 2018-09-19
last_seen: 2024-08-14
first_seen_parent: 2018-05-11
last_seen_parent: 2024-05-14
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 169.7, "avg_administrations": 22}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 13 times with a 6.0 weekly interval (78.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £25,703
first_seen: 2021-08-06
last_seen: 2024-12-13
first_seen_parent: 2019-06-15
last_seen_parent: 2025-11-24
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 228.2, "avg_administrations": 5}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 6 times with a 2.3 weekly interval (13.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £15,968
first_seen: 2018-11-17
last_seen: 2025-06-07
first_seen_parent: 2018-07-22
last_seen_parent: 2024-06-06
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 496.6, "avg_administrations": 28}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 29 times with a 6.1 weekly interval (176.9 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £7,624
first_seen: 2021-11-18
last_seen: 2025-02-16
first_seen_parent: 2017-02-12
last_seen_parent: 2025-11-18
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 100.2, "avg_administrations": 4}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 18 times with a 10.9 weekly interval (196.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £24,464
first_seen: 2021-10-23
last_seen: 2025-09-29
first_seen_parent: 2017-02-12
last_seen_parent: 2025-07-28
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 210.5, "avg_administrations": 8}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 24 times with a 2.7 weekly interval (64.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £24,118
first_seen: 2021-09-11
last_seen: 2024-09-04
first_seen_parent: 2017-07-26
last_seen_parent: 2024-09-09
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 189.9, "avg_administrations": 26}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 7 times with a 5.3 weekly interval (37.1 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £17,182
first_seen: 2018-11-18
last_seen: 2024-03-10
first_seen_parent: 2018-04-22
last_seen_parent: 2025-10-12
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 476.9, "avg_administrations": 18}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 14 times with a 8.6 weekly interval (120.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - ETANERCEPT
labels: BARICITINIB
cost_pp_pa: £8,249
first_seen: 2021-10-26
last_seen: 2024-07-16
first_seen_parent: 2020-03-04
last_seen_parent: 2024-05-05
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - ETANERCEPT - BARICITINIB

average_spacing:
<br><b>ETANERCEPT</b><br>On average given 8 times with a 8.1 weekly interval (64.8 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 5 times with a 6.3 weekly interval (31.5 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 232.7, "avg_administrations": 4}, {"drug": "BARICITINIB", "avg_dose_mg": 458.0, "avg_administrations": 22}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - ETANERCEPT
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - ETANERCEPT - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £7,650
first_seen: 2021-02-01
last_seen: 2024-09-17
first_seen_parent: 2020-03-24
last_seen_parent: 2025-07-14
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 8 times with a 9.9 weekly interval (79.2 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 28 times with a 7.7 weekly interval (215.6 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 237.2, "avg_administrations": 11}, {"drug": "IBRUTINIB", "avg_dose_mg": 111.2, "avg_administrations": 4}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £5,726
first_seen: 2018-03-13
last_seen: 2025-11-17
first_seen_parent: 2019-08-16
last_seen_parent: 2024-08-19
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 386.9, "avg_administrations": 18}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 30 times with a 11.4 weekly interval (342.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - SECUKINUMAB
labels: ADALIMUMAB
cost_pp_pa: £15,755
first_seen: 2021-07-03
last_seen: 2025-10-31
first_seen_parent: 2018-10-29
last_seen_parent: 2025-10-30
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - SECUKINUMAB - ADALIMUMAB

average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 9 times with a 9.7 weekly interval (87.3 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 10 times with a 6.3 weekly interval (63.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 434.8, "avg_administrations": 11}, {"drug": "ADALIMUMAB", "avg_dose_mg": 114.2, "avg_administrations": 29}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £15,500
first_seen: 2020-09-07
last_seen: 2024-12-25
first_seen_parent: 2020-06-21
last_seen_parent: 2025-06-24
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 244.0, "avg_administrations": 24}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 8 times with a 3.5 weekly interval (28.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Atopic dermatitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £26,048
first_seen: 2020-08-28
last_seen: 2024-08-25
first_seen_parent: 2018-02-15
last_seen_parent: 2025-05-01
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 439.2, "avg_administrations": 5}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 14 times with a 3.1 weekly interval (43.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL - RITUXIMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL - RITUXIMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £8,795
first_seen: 2021-05-30
last_seen: 2024-09-12
first_seen_parent: 2021-09-17
last_seen_parent: 2024-02-14
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 13 times with a 9.9 weekly interval (128.7 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 20 times with a 9.5 weekly interval (190.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 116.9, "avg_administrations": 23}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 393.8, "avg_administrations": 28}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £23,735
first_seen: 2020-03-16
last_seen: 2024-01-22
first_seen_parent: 2018-10-03
last_seen_parent: 2025-03-29
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 487.0, "avg_administrations": 6}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 25 times with a 3.3 weekly interval (82.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £13,260
first_seen: 2018-05-27
last_seen: 2024-05-04
first_seen_parent: 2018-09-03
last_seen_parent: 2024-04-25
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 457.3, "avg_administrations": 19}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 24 times with a 8.1 weekly interval (194.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Colorectal cancer - BEVACIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Colorectal cancer - BEVACIZUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £10,716
first_seen: 2020-07-14
last_seen: 2025-03-26
first_seen_parent: 2020-06-16
last_seen_parent: 2025-09-22
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BEVACIZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 5 times with a 4.8 weekly interval (24.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 4 times with a 11.3 weekly interval (45.2 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 225.5, "avg_administrations": 27}, {"drug": "INFLIXIMAB", "avg_dose_mg": 477.8, "avg_administrations": 15}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Colorectal cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £18,659
first_seen: 2021-09-05
last_seen: 2024-05-24
first_seen_parent: 2018-05-21
last_seen_parent: 2024-12-06
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 176.7, "avg_administrations": 9}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 30 times with a 11.1 weekly interval (333.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £18,160
first_seen: 2018-05-16
last_seen: 2025-12-15
first_seen_parent: 2019-12-30
last_seen_parent: 2025-07-16
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 207.6, "avg_administrations": 5}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 10 times with a 8.0 weekly interval (80.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - ADALIMUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - ADALIMUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £9,812
first_seen: 2021-02-25
last_seen: 2025-05-28
first_seen_parent: 2021-03-29
last_seen_parent: 2025-05-21
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11 times with a 4.3 weekly interval (47.3 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 17 times with a 8.3 weekly interval (141.1 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 149.7, "avg_administrations": 23}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 114.3, "avg_administrations": 13}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £12,604
first_seen: 2021-02-23
last_seen: 2025-07-15
first_seen_parent: 2017-06-04
last_seen_parent: 2024-07-20
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 319.3, "avg_administrations": 26}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11 times with a 5.2 weekly interval (57.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £10,099
first_seen: 2020-10-03
last_seen: 2024-12-08
first_seen_parent: 2018-04-27
last_seen_parent: 2025-02-02
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 346.1, "avg_administrations": 15}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 30 times with a 10.1 weekly interval (303.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: PEMBROLIZUMAB
cost_pp_pa: £6,968
first_seen: 2019-01-08
last_seen: 2025-10-04
first_seen_parent: 2020-07-01
last_seen_parent: 2025-11-20
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: AFLIBERCEPT|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Diabetic macular oedema - AFLIBERCEPT - PEMBROLIZUMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 8 times with a 9.2 weekly interval (73.6 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 12 times with a 9.4 weekly interval (112.8 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 326.3, "avg_administrations": 6}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 442.6, "avg_administrations": 15}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: ETANERCEPT
cost_pp_pa: £14,491
first_seen: 2022-08-21
last_seen: 2024-11-12
first_seen_parent: 2020-05-11
last_seen_parent: 2025-07-04
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: AFLIBERCEPT|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Diabetic macular oedema - AFLIBERCEPT - ETANERCEPT

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 28 times with a 10.1 weekly interval (282.8 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 27 times with a 7.9 weekly interval (213.3 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 169.6, "avg_administrations": 14}, {"drug": "ETANERCEPT", "avg_dose_mg": 449.9, "avg_administrations": 29}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Diabetic macular oedema
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £9,155
first_seen: 2021-07-28
last_seen: 2025-07-16
first_seen_parent: 2019-01-22
last_seen_parent: 2024-03-12
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 306.9, "avg_administrations": 21}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 29 times with a 7.0 weekly interval (203.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Giant cell arteritis - TOCILIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Giant cell arteritis - TOCILIZUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £17,036
first_seen: 2019-06-23
last_seen: 2024-02-20
first_seen_parent: 2021-11-05
last_seen_parent: 2025-11-28
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOCILIZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 29 times with a 7.6 weekly interval (220.4 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 14 times with a 10.3 weekly interval (144.2 weeks total treatment length)

average_administered:
[{"drug": "TOCILIZUMAB", "avg_dose_mg": 495.0, "avg_administrations": 5}, {"drug": "INFLIXIMAB", "avg_dose_mg": 166.8, "avg_administrations": 15}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Giant cell arteritis - TOCILIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Giant cell arteritis - TOCILIZUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £12,458
first_seen: 2021-08-05
last_seen: 2025-09-10
first_seen_parent: 2018-08-31
last_seen_parent: 2024-06-21
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOCILIZUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 20 times with a 3.1 weekly interval (62.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 13 times with a 8.6 weekly interval (111.8 weeks total treatment length)

average_administered:
[{"drug": "TOCILIZUMAB", "avg_dose_mg": 288.0, "avg_administrations": 19}, {"drug": "SECUKINUMAB", "avg_dose_mg": 59.2, "avg_administrations": 20}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Giant cell arteritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £14,320
first_seen: 2021-08-31
last_seen: 2025-06-24
first_seen_parent: 2020-05-02
last_seen_parent: 2024-05-17
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 82.9, "avg_administrations": 5}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 4 times with a 4.0 weekly interval (16.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HER2+ breast cancer - TRASTUZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HER2+ breast cancer - TRASTUZUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £15,249
first_seen: 2019-03-13
last_seen: 2025-05-25
first_seen_parent: 2018-04-08
last_seen_parent: 2024-02-16
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TRASTUZUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 10 times with a 2.8 weekly interval (28.0 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 13 times with a 2.3 weekly interval (29.9 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 413.0, "avg_administrations": 23}, {"drug": "NIVOLUMAB", "avg_dose_mg": 75.2, "avg_administrations": 13}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HER2+ breast cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £15,590
first_seen: 2020-08-14
last_seen: 2025-04-13
first_seen_parent: 2018-07-26
last_seen_parent: 2025-04-01
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 101.2, "avg_administrations": 22}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 14 times with a 8.8 weekly interval (123.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Mantle cell lymphoma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £24,524
first_seen: 2019-06-19
last_seen: 2024-06-10
first_seen_parent: 2020-05-30
last_seen_parent: 2025-11-06
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 416.4, "avg_administrations": 18}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 7 times with a 6.8 weekly interval (47.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Melanoma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £21,327
first_seen: 2019-05-08
last_seen: 2025-01-22
first_seen_parent: 2020-05-10
last_seen_parent: 2024-04-22
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 284.5, "avg_administrations": 13}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 16 times with a 2.4 weekly interval (38.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple myeloma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £5,650
first_seen: 2019-04-04
last_seen: 2025-12-19
first_seen_parent: 2018-12-03
last_seen_parent: 2025-11-12
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 239.1, "avg_administrations": 27}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 23 times with a 7.2 weekly interval (165.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £25,188
first_seen: 2019-02-28
last_seen: 2024-10-24
first_seen_parent: 2020-02-25
last_seen_parent: 2024-10-15
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 214.6, "avg_administrations": 7}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 14 times with a 5.7 weekly interval (79.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £13,204
first_seen: 2020-09-15
last_seen: 2024-07-28
first_seen_parent: 2018-05-22
last_seen_parent: 2025-09-30
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 311.0, "avg_administrations": 10}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 19 times with a 6.2 weekly interval (117.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-Hodgkin lymphoma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £11,288
first_seen: 2018-07-18
last_seen: 2024-07-30
first_seen_parent: 2020-08-30
last_seen_parent: 2024-03-29
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 357.3, "avg_administrations": 25}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 7 times with a 6.8 weekly interval (47.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: SECUKINUMAB
cost_pp_pa: £13,757
first_seen: 2019-09-12
last_seen: 2024-09-18
first_seen_parent: 2021-09-03
last_seen_parent: 2024-02-01
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB - SECUKINUMAB

average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 8 times with a 8.6 weekly interval (68.8 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 27 times with a 3.4 weekly interval (91.8 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 488.1, "avg_administrations": 6}, {"drug": "SECUKINUMAB", "avg_dose_mg": 260.5, "avg_administrations": 9}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: NIVOLUMAB
cost_pp_pa: £13,664
first_seen: 2021-09-10
last_seen: 2025-10-01
first_seen_parent: 2018-02-23
last_seen_parent: 2024-08-05
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB - NIVOLUMAB

average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 23 times with a 7.2 weekly interval (165.6 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 15 times with a 6.6 weekly interval (99.0 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 180.7, "avg_administrations": 27}, {"drug": "NIVOLUMAB", "avg_dose_mg": 417.7, "avg_administrations": 30}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £11,368
first_seen: 2018-01-17
last_seen: 2025-06-08
first_seen_parent: 2020-07-30
last_seen_parent: 2024-01-06
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 388.4, "avg_administrations": 10}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 20 times with a 3.0 weekly interval (60.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £18,107
first_seen: 2021-01-27
last_seen: 2024-12-04
first_seen_parent: 2017-08-27
last_seen_parent: 2025-03-08
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 455.7, "avg_administrations": 28}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 26 times with a 9.6 weekly interval (249.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £27,930
first_seen: 2018-12-02
last_seen: 2024-01-27
first_seen_parent: 2020-12-19
last_seen_parent: 2025-11-16
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 68.7, "avg_administrations": 15}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 18 times with a 4.3 weekly interval (77.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £16,692
first_seen: 2019-07-19
last_seen: 2024-09-18
first_seen_parent: 2020-01-31
last_seen_parent: 2025-06-07
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 52.3, "avg_administrations": 14}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 30 times with a 9.3 weekly interval (279.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £3,535
first_seen: 2018-11-20
last_seen: 2024-07-18
first_seen_parent: 2020-03-21
last_seen_parent: 2025-09-27
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 120.1, "avg_administrations": 14}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 23 times with a 8.3 weekly interval (190.9 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £15,555
first_seen: 2020-12-10
last_seen: 2025-11-23
first_seen_parent: 2018-04-04
last_seen_parent: 2024-02-14
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 436.3, "avg_administrations": 20}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 23 times with a 11.0 weekly interval (253.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £5,664
first_seen: 2019-02-09
last_seen: 2024-10-21
first_seen_parent: 2019-09-22
last_seen_parent: 2025-12-27
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 173.2, "avg_administrations": 9}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 25 times with a 4.0 weekly interval (100.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £21,690
first_seen: 2019-04-21
last_seen: 2025-09-15
first_seen_parent: 2020-03-18
last_seen_parent: 2025-12-20
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 362.3, "avg_administrations": 9}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 28 times with a 9.7 weekly interval (271.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Renal cell carcinoma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £17,217
first_seen: 2020-03-12
last_seen: 2024-09-04
first_seen_parent: 2019-04-05
last_seen_parent: 2025-05-24
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 414.4, "avg_administrations": 15}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 16 times with a 5.6 weekly interval (89.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £4,123
first_seen: 2021-11-06
last_seen: 2025-03-29
first_seen_parent: 2019-07-14
last_seen_parent: 2025-06-22
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 437.2, "avg_administrations": 21}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 19 times with a 9.5 weekly interval (180.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £4,487
first_seen: 2019-09-09
last_seen: 2025-09-25
first_seen_parent: 2018-07-28
last_seen_parent: 2024-08-17
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 60.3, "avg_administrations": 26}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 24 times with a 2.8 weekly interval (67.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £22,101
first_seen: 2018-10-10
last_seen: 2024-01-31
first_seen_parent: 2020-11-02
last_seen_parent: 2024-01-23
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 352.8, "avg_administrations": 12}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 26 times with a 3.8 weekly interval (98.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £14,471
first_seen: 2018-10-09
last_seen: 2024-08-06
first_seen_parent: 2019-01-07
last_seen_parent: 2024-01-26
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 431.2, "avg_administrations": 28}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 6 times with a 10.9 weekly interval (65.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £17,348
first_seen: 2019-03-04
last_seen: 2024-02-18
first_seen_parent: 2019-06-01
last_seen_parent: 2024-11-03
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 115.7, "avg_administrations": 22}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 22 times with a 3.7 weekly interval (81.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £17,743
first_seen: 2020-08-03
last_seen: 2025-06-18
first_seen_parent: 2019-09-10
last_seen_parent: 2024-03-04
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 275.5, "avg_administrations": 20}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 6 times with a 4.1 weekly interval (24.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £16,985
first_seen: 2018-03-09
last_seen: 2025-01-14
first_seen_parent: 2018-02-09
last_seen_parent: 2025-09-07
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 451.0, "avg_administrations": 8}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 6 times with a 7.0 weekly interval (42.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - TOFACITINIB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - TOFACITINIB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £14,617
first_seen: 2020-11-12
last_seen: 2024-02-22
first_seen_parent: 2021-07-21
last_seen_parent: 2025-04-04
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOFACITINIB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 27 times with a 7.5 weekly interval (202.5 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 12 times with a 5.6 weekly interval (67.2 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 167.0, "avg_administrations": 30}, {"drug": "USTEKINUMAB", "avg_dose_mg": 249.6, "avg_administrations": 18}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - TOFACITINIB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - TOFACITINIB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £18,755
first_seen: 2022-09-27
last_seen: 2025-11-25
first_seen_parent: 2018-07-09
last_seen_parent: 2024-08-20
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOFACITINIB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 30 times with a 3.2 weekly interval (96.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 22 times with a 6.7 weekly interval (147.4 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 211.7, "avg_administrations": 13}, {"drug": "SECUKINUMAB", "avg_dose_mg": 348.7, "avg_administrations": 7}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £16,677
first_seen: 2020-06-26
last_seen: 2024-05-12
first_seen_parent: 2020-03-27
last_seen_parent: 2025-02-07
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 112.6, "avg_administrations": 6}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 25 times with a 2.5 weekly interval (62.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Uveitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £7,587
first_seen: 2021-04-11
last_seen: 2025-01-01
first_seen_parent: 2017-06-19
last_seen_parent: 2025-12-10
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 156.7, "avg_administrations": 13}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11 times with a 2.3 weekly interval (25.3 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - AFLIBERCEPT
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - AFLIBERCEPT - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £15,042
first_seen: 2019-01-21
last_seen: 2024-04-01
first_seen_parent: 2021-09-10
last_seen_parent: 2025-03-17
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: AFLIBERCEPT|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 19 times with a 2.6 weekly interval (49.4 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 19 times with a 7.9 weekly interval (150.1 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 497.3, "avg_administrations": 25}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 336.3, "avg_administrations": 7}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - AFLIBERCEPT
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - AFLIBERCEPT - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £3,726
first_seen: 2020-11-18
last_seen: 2025-07-10
first_seen_parent: 2020-03-05
last_seen_parent: 2024-11-28
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: AFLIBERCEPT|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 13 times with a 6.4 weekly interval (83.2 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 28 times with a 5.1 weekly interval (142.8 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 255.2, "avg_administrations": 13}, {"drug": "INFLIXIMAB", "avg_dose_mg": 343.0, "avg_administrations": 28}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £8,267
first_seen: 2020-11-21
last_seen: 2025-02-04
first_seen_parent: 2019-05-11
last_seen_parent: 2024-09-22
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 296.7, "avg_administrations": 12}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 29 times with a 6.5 weekly interval (188.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £7,501
first_seen: 2021-03-27
last_seen: 2024-02-24
first_seen_parent: 2018-06-18
last_seen_parent: 2024-10-05
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 319.0, "avg_administrations": 19}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 14 times with a 8.8 weekly interval (123.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Atopic dermatitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £12,460
first_seen: 2019-02-21
last_seen: 2024-06-25
first_seen_parent: 2017-02-06
last_seen_parent: 2024-12-29
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 480.9, "avg_administrations": 30}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 6 times with a 8.6 weekly interval (51.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £16,745
first_seen: 2018-03-15
last_seen: 2024-02-22
first_seen_parent: 2019-09-07
last_seen_parent: 2024-12-12
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 62.1, "avg_administrations": 16}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 30 times with a 9.8 weekly interval (294.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £20,242
first_seen: 2018-09-12
last_seen: 2025-09-09
first_seen_parent: 2019-05-20
last_seen_parent: 2025-11-02
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 235.9, "avg_administrations": 4}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 7 times with a 5.0 weekly interval (35.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Colorectal cancer - BEVACIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Colorectal cancer - BEVACIZUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £8,843
first_seen: 2021-07-06
last_seen: 2024-12-08
first_seen_parent: 2021-07-07
last_seen_parent: 2025-05-28
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BEVACIZUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 8 times with a 5.4 weekly interval (43.2 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 7 times with a 3.3 weekly interval (23.1 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 96.5, "avg_administrations": 28}, {"drug": "NIVOLUMAB", "avg_dose_mg": 331.0, "avg_administrations": 18}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Colorectal cancer - BEVACIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Colorectal cancer - BEVACIZUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £23,321
first_seen: 2022-06-21
last_seen: 2025-05-01
first_seen_parent: 2018-09-08
last_seen_parent: 2024-02-07
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BEVACIZUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 4 times with a 7.1 weekly interval (28.4 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 17 times with a 10.5 weekly interval (178.5 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 101.0, "avg_administrations": 16}, {"drug": "IBRUTINIB", "avg_dose_mg": 176.2, "avg_administrations": 20}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Colorectal cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £5,481
first_seen: 2018-06-05
last_seen: 2024-05-09
first_seen_parent: 2019-12-06
last_seen_parent: 2025-11-13
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 151.5, "avg_administrations": 23}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 10 times with a 9.1 weekly interval (91.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £16,993
first_seen: 2019-10-29
last_seen: 2024-08-21
first_seen_parent: 2018-12-28
last_seen_parent: 2024-01-12
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 339.1, "avg_administrations": 11}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 11 times with a 9.3 weekly interval (102.3 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £10,906
first_seen: 2018-11-01
last_seen: 2025-02-12
first_seen_parent: 2019-07-03
last_seen_parent: 2025-09-14
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 437.0, "avg_administrations": 19}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 16 times with a 8.3 weekly interval (132.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Diabetic macular oedema
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £7,467
first_seen: 2020-11-15
last_seen: 2024-02-01
first_seen_parent: 2019-04-28
last_seen_parent: 2024-09-02
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 244.7, "avg_administrations": 4}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 14 times with a 3.0 weekly interval (42.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £13,232
first_seen: 2019-04-18
last_seen: 2025-08-16
first_seen_parent: 2020-04-01
last_seen_parent: 2025-11-19
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOCILIZUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB - PEMBROLIZUMAB

average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 5 times with a 2.1 weekly interval (10.5 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 10 times with a 5.7 weekly interval (57.0 weeks total treatment length)

average_administered:
[{"drug": "TOCILIZUMAB", "avg_dose_mg": 186.5, "avg_administrations": 14}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 343.8, "avg_administrations": 27}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Giant cell arteritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £5,627
first_seen: 2020-01-06
last_seen: 2024-11-05
first_seen_parent: 2019-06-20
last_seen_parent: 2025-09-10
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 452.3, "avg_administrations": 15}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 15 times with a 8.3 weekly interval (124.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HER2+ breast cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £6,527
first_seen: 2020-02-26
last_seen: 2024-11-29
first_seen_parent: 2018-11-28
last_seen_parent: 2024-07-09
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 150.7, "avg_administrations": 18}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 28 times with a 11.7 weekly interval (327.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Mantle cell lymphoma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £12,647
first_seen: 2018-09-16
last_seen: 2024-01-09
first_seen_parent: 2020-10-12
last_seen_parent: 2025-04-06
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 189.2, "avg_administrations": 16}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 28 times with a 6.9 weekly interval (193.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Melanoma - PEMBROLIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Melanoma - PEMBROLIZUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £16,839
first_seen: 2020-03-18
last_seen: 2024-03-16
first_seen_parent: 2021-01-21
last_seen_parent: 2024-01-29
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: PEMBROLIZUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 17 times with a 10.0 weekly interval (170.0 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 8 times with a 2.4 weekly interval (19.2 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 60.6, "avg_administrations": 15}, {"drug": "NATALIZUMAB", "avg_dose_mg": 488.2, "avg_administrations": 7}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Melanoma - PEMBROLIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Melanoma - PEMBROLIZUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £17,223
first_seen: 2020-09-08
last_seen: 2025-04-09
first_seen_parent: 2018-09-14
last_seen_parent: 2024-01-16
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: PEMBROLIZUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 5 times with a 10.5 weekly interval (52.5 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 17 times with a 3.8 weekly interval (64.6 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 300.9, "avg_administrations": 16}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 347.0, "avg_administrations": 30}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Melanoma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £5,159
first_seen: 2020-05-26
last_seen: 2024-11-12
first_seen_parent: 2017-11-01
last_seen_parent: 2025-04-30
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 322.7, "avg_administrations": 4}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 5 times with a 6.9 weekly interval (34.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple myeloma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £6,726
first_seen: 2020-09-23
last_seen: 2024-12-10
first_seen_parent: 2019-12-18
last_seen_parent: 2024-06-29
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 244.9, "avg_administrations": 6}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 8 times with a 8.0 weekly interval (64.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £5,004
first_seen: 2021-02-13
last_seen: 2024-05-30
first_seen_parent: 2020-08-01
last_seen_parent: 2025-12-11
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: OCRELIZUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 11 times with a 4.7 weekly interval (51.7 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 11 times with a 3.3 weekly interval (36.3 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 307.4, "avg_administrations": 22}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 193.0, "avg_administrations": 26}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £16,097
first_seen: 2019-01-17
last_seen: 2024-07-28
first_seen_parent: 2021-10-12
last_seen_parent: 2025-12-10
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: OCRELIZUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 6 times with a 8.1 weekly interval (48.6 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 12 times with a 6.1 weekly interval (73.2 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 329.5, "avg_administrations": 24}, {"drug": "NATALIZUMAB", "avg_dose_mg": 266.4, "avg_administrations": 11}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £11,727
first_seen: 2021-10-26
last_seen: 2025-09-24
first_seen_parent: 2017-11-09
last_seen_parent: 2024-01-25
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 259.0, "avg_administrations": 5}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 16 times with a 6.9 weekly interval (110.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - NATALIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - NATALIZUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £18,957
first_seen: 2020-10-25
last_seen: 2024-10-03
first_seen_parent: 2018-10-03
last_seen_parent: 2025-07-14
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NATALIZUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 12 times with a 4.4 weekly interval (52.8 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 12 times with a 5.3 weekly interval (63.6 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 434.6, "avg_administrations": 6}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 425.5, "avg_administrations": 25}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - NATALIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - NATALIZUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £7,592
first_seen: 2021-10-26
last_seen: 2024-01-13
first_seen_parent: 2019-09-27
last_seen_parent: 2024-03-13
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NATALIZUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 6 times with a 6.8 weekly interval (40.8 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 28 times with a 8.3 weekly interval (232.4 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 220.7, "avg_administrations": 29}, {"drug": "RITUXIMAB", "avg_dose_mg": 357.0, "avg_administrations": 10}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £14,998
first_seen: 2020-07-15
last_seen: 2024-09-06
first_seen_parent: 2019-07-29
last_seen_parent: 2025-03-08
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 414.2, "avg_administrations": 8}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 12 times with a 9.1 weekly interval (109.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-Hodgkin lymphoma - RITUXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-Hodgkin lymphoma - RITUXIMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £6,393
first_seen: 2022-08-29
last_seen: 2024-11-17
first_seen_parent: 2021-02-16
last_seen_parent: 2024-09-21
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 16 times with a 8.2 weekly interval (131.2 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 8 times with a 3.8 weekly interval (30.4 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 195.8, "avg_administrations": 20}, {"drug": "TOFACITINIB", "avg_dose_mg": 132.0, "avg_administrations": 30}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-Hodgkin lymphoma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £9,576
first_seen: 2020-03-31
last_seen: 2024-03-04
first_seen_parent: 2018-07-29
last_seen_parent: 2024-08-18
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 153.0, "avg_administrations": 10}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 10 times with a 9.9 weekly interval (99.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £5,924
first_seen: 2019-08-18
last_seen: 2024-12-25
first_seen_parent: 2020-08-06
last_seen_parent: 2025-09-21
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 458.9, "avg_administrations": 20}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 18 times with a 3.5 weekly interval (63.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £4,970
first_seen: 2019-12-01
last_seen: 2024-10-29
first_seen_parent: 2019-04-14
last_seen_parent: 2025-02-14
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NIVOLUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB - PEMBROLIZUMAB

average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 8 times with a 10.9 weekly interval (87.2 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 28 times with a 3.5 weekly interval (98.0 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 305.9, "avg_administrations": 27}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 416.2, "avg_administrations": 22}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB
labels: IBRUTINIB
cost_pp_pa: £7,723
first_seen: 2022-06-13
last_seen: 2025-10-24
first_seen_parent: 2018-06-30
last_seen_parent: 2024-07-21
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NIVOLUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB - IBRUTINIB

average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 30 times with a 6.2 weekly interval (186.0 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 15 times with a 10.6 weekly interval (159.0 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 123.3, "avg_administrations": 30}, {"drug": "IBRUTINIB", "avg_dose_mg": 84.1, "avg_administrations": 5}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £9,378
first_seen: 2019-06-12
last_seen: 2025-02-23
first_seen_parent: 2020-03-03
last_seen_parent: 2024-10-02
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 492.5, "avg_administrations": 30}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 16 times with a 9.9 weekly interval (158.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £11,710
first_seen: 2020-10-22
last_seen: 2024-04-30
first_seen_parent: 2017-01-28
last_seen_parent: 2025-05-09
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 390.5, "avg_administrations": 23}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 24 times with a 8.4 weekly interval (201.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - ADALIMUMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £4,121
first_seen: 2022-08-26
last_seen: 2024-07-19
first_seen_parent: 2018-04-19
last_seen_parent: 2025-08-20
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5 times with a 10.3 weekly interval (51.5 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 20 times with a 2.5 weekly interval (50.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 166.7, "avg_administrations": 18}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 363.4, "avg_administrations": 5}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £6,478
first_seen: 2020-10-02
last_seen: 2025-11-12
first_seen_parent: 2017-12-09
last_seen_parent: 2024-05-31
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 138.2, "avg_administrations": 6}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 25 times with a 9.1 weekly interval (227.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - SECUKINUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - SECUKINUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £7,252
first_seen: 2019-06-18
last_seen: 2024-04-29
first_seen_parent: 2021-10-01
last_seen_parent: 2025-05-18
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 6 times with a 3.0 weekly interval (18.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 9 times with a 7.8 weekly interval (70.2 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 380.0, "avg_administrations": 15}, {"drug": "TOFACITINIB", "avg_dose_mg": 170.1, "avg_administrations": 4}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £11,982
first_seen: 2020-11-05
last_seen: 2024-09-29
first_seen_parent: 2020-11-26
last_seen_parent: 2024-06-23
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 252.0, "avg_administrations": 24}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 20 times with a 2.4 weekly interval (48.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £12,077
first_seen: 2019-02-16
last_seen: 2025-09-13
first_seen_parent: 2017-04-14
last_seen_parent: 2024-03-22
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 225.0, "avg_administrations": 15}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 7 times with a 7.4 weekly interval (51.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £6,148
first_seen: 2019-12-05
last_seen: 2024-01-18
first_seen_parent: 2018-09-01
last_seen_parent: 2025-03-24
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 414.1, "avg_administrations": 17}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 22 times with a 2.1 weekly interval (46.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £5,867
first_seen: 2020-12-17
last_seen: 2024-10-28
first_seen_parent: 2018-03-07
last_seen_parent: 2025-02-12
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 263.4, "avg_administrations": 6}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 11 times with a 11.9 weekly interval (130.9 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £16,263
first_seen: 2022-10-31
last_seen: 2025-02-21
first_seen_parent: 2018-11-16
last_seen_parent: 2024-07-08
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NIVOLUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 15 times with a 8.8 weekly interval (132.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 24 times with a 11.7 weekly interval (280.8 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 370.2, "avg_administrations": 7}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 452.1, "avg_administrations": 30}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Renal cell carcinoma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £7,363
first_seen: 2019-12-08
last_seen: 2024-03-09
first_seen_parent: 2020-12-23
last_seen_parent: 2025-11-01
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 227.1, "avg_administrations": 8}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 13 times with a 10.2 weekly interval (132.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £19,961
first_seen: 2021-04-14
last_seen: 2025-06-17
first_seen_parent: 2018-09-10
last_seen_parent: 2024-06-08
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 263.0, "avg_administrations": 25}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 24 times with a 10.0 weekly interval (240.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £18,868
first_seen: 2019-05-17
last_seen: 2024-10-19
first_seen_parent: 2017-07-16
last_seen_parent: 2025-07-06
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 305.0, "avg_administrations": 6}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 8 times with a 2.0 weekly interval (16.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £16,659
first_seen: 2019-08-08
last_seen: 2024-06-03
first_seen_parent: 2019-10-20
last_seen_parent: 2025-05-31
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 251.4, "avg_administrations": 14}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 16 times with a 4.2 weekly interval (67.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £11,023
first_seen: 2019-11-17
last_seen: 2024-02-13
first_seen_parent: 2019-11-10
last_seen_parent: 2024-11-28
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 369.4, "avg_administrations": 4}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 11 times with a 5.7 weekly interval (62.7 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - VEDOLIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - VEDOLIZUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £5,586
first_seen: 2020-04-23
last_seen: 2025-04-20
first_seen_parent: 2021-04-19
last_seen_parent: 2024-05-29
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: VEDOLIZUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 5 times with a 7.7 weekly interval (38.5 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 22 times with a 3.1 weekly interval (68.2 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 307.5, "avg_administrations": 22}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 102.2, "avg_administrations": 18}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - TOFACITINIB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - TOFACITINIB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £19,528
first_seen: 2020-10-07
last_seen: 2025-12-09
first_seen_parent: 2020-12-04
last_seen_parent: 2025-08-08
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOFACITINIB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 18 times with a 11.5 weekly interval (207.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 9 times with a 4.9 weekly interval (44.1 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 192.7, "avg_administrations": 20}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 164.3, "avg_administrations": 11}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - TOFACITINIB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - TOFACITINIB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £8,500
first_seen: 2020-08-21
last_seen: 2024-12-29
first_seen_parent: 2019-09-09
last_seen_parent: 2025-09-20
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOFACITINIB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 20 times with a 6.0 weekly interval (120.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 27 times with a 4.7 weekly interval (126.9 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 255.1, "avg_administrations": 8}, {"drug": "RITUXIMAB", "avg_dose_mg": 300.1, "avg_administrations": 10}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £19,243
first_seen: 2021-09-22
last_seen: 2025-01-27
first_seen_parent: 2020-07-01
last_seen_parent: 2024-07-11
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 398.7, "avg_administrations": 4}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 14 times with a 4.8 weekly interval (67.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Uveitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £4,710
first_seen: 2019-12-02
last_seen: 2025-10-16
first_seen_parent: 2020-11-16
last_seen_parent: 2024-01-05
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 132.3, "avg_administrations": 9}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 17 times with a 5.0 weekly interval (85.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - AFLIBERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - AFLIBERCEPT - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £8,074
first_seen: 2019-07-24
last_seen: 2024-05-05
first_seen_parent: 2021-03-01
last_seen_parent: 2025-09-23
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: AFLIBERCEPT|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 28 times with a 7.7 weekly interval (215.6 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 30 times with a 11.3 weekly interval (339.0 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 189.0, "avg_administrations": 13}, {"drug": "IBRUTINIB", "avg_dose_mg": 128.3, "avg_administrations": 19}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - AFLIBERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - AFLIBERCEPT - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £18,284
first_seen: 2022-11-13
last_seen: 2024-01-24
first_seen_parent: 2020-06-25
last_seen_parent: 2024-01-29
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: AFLIBERCEPT|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 11 times with a 9.4 weekly interval (103.4 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 13 times with a 5.9 weekly interval (76.7 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 401.5, "avg_administrations": 20}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 62.7, "avg_administrations": 23}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £5,257
first_seen: 2019-05-13
last_seen: 2024-07-08
first_seen_parent: 2017-12-26
last_seen_parent: 2025-07-10
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 154.7, "avg_administrations": 9}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 9 times with a 11.8 weekly interval (106.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £22,763
first_seen: 2018-07-17
last_seen: 2024-11-17
first_seen_parent: 2017-08-19
last_seen_parent: 2024-02-12
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 478.7, "avg_administrations": 11}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 17 times with a 8.5 weekly interval (144.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £7,429
first_seen: 2018-04-29
last_seen: 2025-11-22
first_seen_parent: 2020-11-27
last_seen_parent: 2024-11-01
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 209.8, "avg_administrations": 12}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 21 times with a 4.2 weekly interval (88.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £15,120
first_seen: 2019-02-01
last_seen: 2025-01-04
first_seen_parent: 2019-10-27
last_seen_parent: 2024-02-03
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 64.9, "avg_administrations": 23}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 9 times with a 2.4 weekly interval (21.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Atopic dermatitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £7,468
first_seen: 2020-11-12
last_seen: 2024-03-27
first_seen_parent: 2019-04-05
last_seen_parent: 2024-05-27
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 211.1, "avg_administrations": 15}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 10 times with a 5.7 weekly interval (57.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £10,815
first_seen: 2020-06-23
last_seen: 2025-06-25
first_seen_parent: 2017-06-23
last_seen_parent: 2025-08-01
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 110.0, "avg_administrations": 22}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 14 times with a 9.1 weekly interval (127.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £22,224
first_seen: 2020-07-22
last_seen: 2025-08-27
first_seen_parent: 2017-10-09
last_seen_parent: 2024-05-08
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 150.1, "avg_administrations": 11}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 26 times with a 5.6 weekly interval (145.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Colorectal cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £14,900
first_seen: 2018-04-18
last_seen: 2025-02-10
first_seen_parent: 2018-07-27
last_seen_parent: 2024-02-14
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 367.8, "avg_administrations": 15}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 29 times with a 10.6 weekly interval (307.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £5,679
first_seen: 2020-02-01
last_seen: 2024-11-26
first_seen_parent: 2019-01-14
last_seen_parent: 2024-04-09
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 239.6, "avg_administrations": 24}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 27 times with a 6.3 weekly interval (170.1 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - INFLIXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - INFLIXIMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £19,096
first_seen: 2022-05-30
last_seen: 2025-05-25
first_seen_parent: 2020-11-16
last_seen_parent: 2025-12-01
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: INFLIXIMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 27 times with a 6.3 weekly interval (170.1 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 18 times with a 6.6 weekly interval (118.8 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 200.5, "avg_administrations": 13}, {"drug": "USTEKINUMAB", "avg_dose_mg": 50.6, "avg_administrations": 27}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £9,633
first_seen: 2018-06-26
last_seen: 2025-06-19
first_seen_parent: 2020-05-09
last_seen_parent: 2025-09-22
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 249.3, "avg_administrations": 24}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 16 times with a 2.9 weekly interval (46.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - USTEKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - USTEKINUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £13,175
first_seen: 2020-02-07
last_seen: 2024-10-20
first_seen_parent: 2020-11-16
last_seen_parent: 2024-11-28
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: USTEKINUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 7 times with a 7.8 weekly interval (54.6 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 20 times with a 10.0 weekly interval (200.0 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 373.4, "avg_administrations": 19}, {"drug": "SECUKINUMAB", "avg_dose_mg": 271.4, "avg_administrations": 7}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - USTEKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - USTEKINUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £3,170
first_seen: 2022-08-09
last_seen: 2025-12-27
first_seen_parent: 2020-04-24
last_seen_parent: 2025-06-30
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: USTEKINUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 28 times with a 2.6 weekly interval (72.8 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 23 times with a 7.8 weekly interval (179.4 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 252.7, "avg_administrations": 20}, {"drug": "NATALIZUMAB", "avg_dose_mg": 119.6, "avg_administrations": 17}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £21,792
first_seen: 2018-12-28
last_seen: 2025-03-10
first_seen_parent: 2017-11-15
last_seen_parent: 2025-04-26
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 447.1, "avg_administrations": 6}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 27 times with a 10.1 weekly interval (272.7 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £18,813
first_seen: 2021-09-11
last_seen: 2024-07-13
first_seen_parent: 2017-01-31
last_seen_parent: 2024-10-17
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 292.2, "avg_administrations": 16}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 17 times with a 11.7 weekly interval (198.9 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Diabetic macular oedema - AFLIBERCEPT
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Diabetic macular oedema - AFLIBERCEPT - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £8,287
first_seen: 2022-10-11
last_seen: 2025-08-16
first_seen_parent: 2019-06-16
last_seen_parent: 2025-11-10
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: AFLIBERCEPT|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 15 times with a 6.1 weekly interval (91.5 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 15 times with a 7.0 weekly interval (105.0 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 64.2, "avg_administrations": 10}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 192.5, "avg_administrations": 14}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Diabetic macular oedema
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £10,145
first_seen: 2021-07-16
last_seen: 2024-08-09
first_seen_parent: 2019-06-27
last_seen_parent: 2024-06-18
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 398.5, "avg_administrations": 27}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 5 times with a 5.0 weekly interval (25.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Giant cell arteritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £15,204
first_seen: 2018-03-02
last_seen: 2024-06-21
first_seen_parent: 2018-11-30
last_seen_parent: 2025-12-10
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 177.4, "avg_administrations": 17}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 22 times with a 6.0 weekly interval (132.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HER2+ breast cancer - TRASTUZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HER2+ breast cancer - TRASTUZUMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £16,644
first_seen: 2021-02-13
last_seen: 2024-09-25
first_seen_parent: 2021-08-01
last_seen_parent: 2025-07-14
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TRASTUZUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 26 times with a 11.5 weekly interval (299.0 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 13 times with a 8.7 weekly interval (113.1 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 264.5, "avg_administrations": 11}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 421.5, "avg_administrations": 4}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HER2+ breast cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £18,152
first_seen: 2021-04-14
last_seen: 2024-02-13
first_seen_parent: 2017-03-25
last_seen_parent: 2025-07-23
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 410.1, "avg_administrations": 11}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 24 times with a 4.9 weekly interval (117.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Mantle cell lymphoma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £24,861
first_seen: 2018-06-15
last_seen: 2025-10-17
first_seen_parent: 2020-06-18
last_seen_parent: 2024-03-04
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 63.5, "avg_administrations": 26}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 6 times with a 6.9 weekly interval (41.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Melanoma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £13,987
first_seen: 2021-02-03
last_seen: 2025-12-13
first_seen_parent: 2019-09-19
last_seen_parent: 2024-05-09
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 446.3, "avg_administrations": 14}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 18 times with a 8.8 weekly interval (158.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple myeloma - LENALIDOMIDE
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple myeloma - LENALIDOMIDE - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £9,335
first_seen: 2020-10-02
last_seen: 2025-04-22
first_seen_parent: 2019-07-22
last_seen_parent: 2025-08-09
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: LENALIDOMIDE|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 4 times with a 10.1 weekly interval (40.4 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 9 times with a 9.9 weekly interval (89.1 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 462.8, "avg_administrations": 18}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 124.0, "avg_administrations": 27}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple myeloma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £21,651
first_seen: 2020-10-21
last_seen: 2025-11-20
first_seen_parent: 2019-08-16
last_seen_parent: 2025-08-29
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 221.2, "avg_administrations": 23}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 4 times with a 7.7 weekly interval (30.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - OCRELIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - OCRELIZUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £6,143
first_seen: 2019-11-29
last_seen: 2024-04-01
first_seen_parent: 2019-02-27
last_seen_parent: 2025-06-23
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: OCRELIZUMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 7 times with a 11.8 weekly interval (82.6 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 14 times with a 11.2 weekly interval (156.8 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 448.2, "avg_administrations": 25}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 319.3, "avg_administrations": 4}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £10,373
first_seen: 2019-05-02
last_seen: 2024-08-06
first_seen_parent: 2018-01-25
last_seen_parent: 2024-11-08
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 165.7, "avg_administrations": 12}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 29 times with a 10.8 weekly interval (313.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - NATALIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - NATALIZUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £6,036
first_seen: 2020-06-25
last_seen: 2024-06-15
first_seen_parent: 2018-08-11
last_seen_parent: 2025-12-19
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NATALIZUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 13 times with a 11.0 weekly interval (143.0 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 8 times with a 2.9 weekly interval (23.2 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 80.8, "avg_administrations": 28}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 479.0, "avg_administrations": 29}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £15,311
first_seen: 2021-09-30
last_seen: 2025-01-01
first_seen_parent: 2018-06-07
last_seen_parent: 2025-11-07
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 435.6, "avg_administrations": 11}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 14 times with a 5.1 weekly interval (71.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-Hodgkin lymphoma - RITUXIMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £14,238
first_seen: 2020-07-27
last_seen: 2024-07-02
first_seen_parent: 2019-08-17
last_seen_parent: 2024-04-04
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RITUXIMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 7 times with a 5.2 weekly interval (36.4 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 25 times with a 8.0 weekly interval (200.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 55.8, "avg_administrations": 22}, {"drug": "BARICITINIB", "avg_dose_mg": 187.4, "avg_administrations": 29}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-Hodgkin lymphoma - RITUXIMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £9,516
first_seen: 2021-05-12
last_seen: 2025-05-27
first_seen_parent: 2018-04-30
last_seen_parent: 2025-11-09
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RITUXIMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 27 times with a 8.6 weekly interval (232.2 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 18 times with a 2.8 weekly interval (50.4 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 151.7, "avg_administrations": 11}, {"drug": "NIVOLUMAB", "avg_dose_mg": 51.8, "avg_administrations": 28}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-Hodgkin lymphoma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £26,648
first_seen: 2019-12-07
last_seen: 2024-09-20
first_seen_parent: 2019-11-13
last_seen_parent: 2024-02-07
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 56.9, "avg_administrations": 26}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 25 times with a 6.6 weekly interval (165.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £9,305
first_seen: 2021-07-26
last_seen: 2024-05-29
first_seen_parent: 2019-01-15
last_seen_parent: 2025-05-20
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 374.7, "avg_administrations": 14}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 13 times with a 11.3 weekly interval (146.9 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - NIVOLUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - NIVOLUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £5,392
first_seen: 2021-09-03
last_seen: 2025-03-04
first_seen_parent: 2019-07-30
last_seen_parent: 2024-11-16
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NIVOLUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 17 times with a 5.2 weekly interval (88.4 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 20 times with a 5.9 weekly interval (118.0 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 396.8, "avg_administrations": 29}, {"drug": "SECUKINUMAB", "avg_dose_mg": 86.2, "avg_administrations": 21}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £16,975
first_seen: 2020-01-22
last_seen: 2024-07-23
first_seen_parent: 2018-05-16
last_seen_parent: 2025-09-13
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 418.5, "avg_administrations": 20}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 23 times with a 6.0 weekly interval (138.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £11,248
first_seen: 2018-03-05
last_seen: 2024-03-10
first_seen_parent: 2018-12-01
last_seen_parent: 2024-02-06
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 151.1, "avg_administrations": 16}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 25 times with a 2.6 weekly interval (65.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - ADALIMUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £4,655
first_seen: 2021-11-17
last_seen: 2024-12-03
first_seen_parent: 2018-11-10
last_seen_parent: 2024-09-25
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 30 times with a 7.7 weekly interval (231.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 21 times with a 8.8 weekly interval (184.8 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 460.9, "avg_administrations": 29}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 231.7, "avg_administrations": 6}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - ADALIMUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £9,290
first_seen: 2020-10-22
last_seen: 2025-02-09
first_seen_parent: 2021-05-24
last_seen_parent: 2024-08-17
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5 times with a 3.7 weekly interval (18.5 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 5 times with a 6.8 weekly interval (34.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 407.3, "avg_administrations": 5}, {"drug": "TOFACITINIB", "avg_dose_mg": 211.6, "avg_administrations": 11}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £5,855
first_seen: 2019-12-20
last_seen: 2025-01-19
first_seen_parent: 2017-04-11
last_seen_parent: 2024-10-06
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 97.8, "avg_administrations": 17}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8 times with a 5.9 weekly interval (47.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £12,213
first_seen: 2018-10-19
last_seen: 2024-01-25
first_seen_parent: 2020-09-05
last_seen_parent: 2025-02-12
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 355.5, "avg_administrations": 10}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 9 times with a 6.3 weekly interval (56.7 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - USTEKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - USTEKINUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £8,050
first_seen: 2020-07-26
last_seen: 2024-01-30
first_seen_parent: 2020-04-13
last_seen_parent: 2024-05-06
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: USTEKINUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 26 times with a 3.9 weekly interval (101.4 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 15 times with a 7.4 weekly interval (111.0 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 224.8, "avg_administrations": 10}, {"drug": "SECUKINUMAB", "avg_dose_mg": 138.0, "avg_administrations": 19}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - USTEKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - USTEKINUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £15,795
first_seen: 2019-11-26
last_seen: 2025-08-13
first_seen_parent: 2021-08-04
last_seen_parent: 2025-07-16
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: USTEKINUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 12 times with a 2.8 weekly interval (33.6 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 16 times with a 11.2 weekly interval (179.2 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 426.3, "avg_administrations": 10}, {"drug": "IBRUTINIB", "avg_dose_mg": 198.1, "avg_administrations": 24}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £6,493
first_seen: 2021-07-20
last_seen: 2024-12-07
first_seen_parent: 2018-02-15
last_seen_parent: 2024-01-19
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 484.6, "avg_administrations": 15}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 8 times with a 11.5 weekly interval (92.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis - ETANERCEPT
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis - ETANERCEPT - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £10,945
first_seen: 2021-12-30
last_seen: 2025-05-26
first_seen_parent: 2019-12-09
last_seen_parent: 2024-12-08
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ETANERCEPT|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 27 times with a 7.1 weekly interval (191.7 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 10 times with a 7.4 weekly interval (74.0 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 460.9, "avg_administrations": 22}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 296.1, "avg_administrations": 30}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis - ETANERCEPT
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis - ETANERCEPT - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £8,085
first_seen: 2020-12-03
last_seen: 2025-08-26
first_seen_parent: 2019-05-11
last_seen_parent: 2025-02-01
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ETANERCEPT|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 5 times with a 5.0 weekly interval (25.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 15 times with a 6.3 weekly interval (94.5 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 386.4, "avg_administrations": 27}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 403.7, "avg_administrations": 12}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £18,383
first_seen: 2021-05-13
last_seen: 2025-02-01
first_seen_parent: 2017-12-01
last_seen_parent: 2024-07-01
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 412.9, "avg_administrations": 5}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 24 times with a 7.4 weekly interval (177.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £7,026
first_seen: 2021-04-12
last_seen: 2025-11-10
first_seen_parent: 2017-05-27
last_seen_parent: 2024-04-27
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 182.5, "avg_administrations": 15}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 5 times with a 8.4 weekly interval (42.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Renal cell carcinoma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £5,656
first_seen: 2018-05-19
last_seen: 2025-06-07
first_seen_parent: 2018-06-05
last_seen_parent: 2024-11-30
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 293.7, "avg_administrations": 20}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 17 times with a 8.8 weekly interval (149.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - ADALIMUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £21,925
first_seen: 2021-01-07
last_seen: 2024-05-09
first_seen_parent: 2019-11-01
last_seen_parent: 2024-07-28
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10 times with a 2.7 weekly interval (27.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 14 times with a 11.1 weekly interval (155.4 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 54.7, "avg_administrations": 16}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 332.8, "avg_administrations": 21}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - ADALIMUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £12,160
first_seen: 2020-04-22
last_seen: 2025-07-20
first_seen_parent: 2018-07-23
last_seen_parent: 2024-10-12
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 12 times with a 5.3 weekly interval (63.6 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 6 times with a 6.9 weekly interval (41.4 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 456.0, "avg_administrations": 30}, {"drug": "NATALIZUMAB", "avg_dose_mg": 316.9, "avg_administrations": 25}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £7,865
first_seen: 2021-05-08
last_seen: 2025-02-20
first_seen_parent: 2019-02-28
last_seen_parent: 2025-08-27
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 84.8, "avg_administrations": 9}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11 times with a 7.8 weekly interval (85.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £20,398
first_seen: 2019-08-27
last_seen: 2024-01-19
first_seen_parent: 2019-04-20
last_seen_parent: 2024-05-22
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 100.9, "avg_administrations": 25}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 11 times with a 5.3 weekly interval (58.3 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £6,371
first_seen: 2018-02-25
last_seen: 2025-06-20
first_seen_parent: 2019-02-13
last_seen_parent: 2024-03-26
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 169.0, "avg_administrations": 26}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 27 times with a 9.9 weekly interval (267.3 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - INFLIXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - INFLIXIMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £10,743
first_seen: 2021-03-28
last_seen: 2024-09-14
first_seen_parent: 2020-07-13
last_seen_parent: 2024-09-11
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: INFLIXIMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 24 times with a 7.2 weekly interval (172.8 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 21 times with a 2.9 weekly interval (60.9 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 211.0, "avg_administrations": 6}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 274.3, "avg_administrations": 18}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £6,547
first_seen: 2020-02-28
last_seen: 2024-06-11
first_seen_parent: 2019-02-09
last_seen_parent: 2024-01-27
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 51.3, "avg_administrations": 21}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 27 times with a 11.0 weekly interval (297.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - VEDOLIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - VEDOLIZUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £4,975
first_seen: 2021-11-24
last_seen: 2025-02-17
first_seen_parent: 2020-02-27
last_seen_parent: 2025-03-13
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: VEDOLIZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 16 times with a 6.9 weekly interval (110.4 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 12 times with a 10.1 weekly interval (121.2 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 114.5, "avg_administrations": 10}, {"drug": "TOFACITINIB", "avg_dose_mg": 277.5, "avg_administrations": 22}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - VEDOLIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - VEDOLIZUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £14,400
first_seen: 2019-01-19
last_seen: 2024-06-01
first_seen_parent: 2019-08-29
last_seen_parent: 2024-04-04
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: VEDOLIZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 13 times with a 6.4 weekly interval (83.2 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 10 times with a 8.9 weekly interval (89.0 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 112.3, "avg_administrations": 6}, {"drug": "INFLIXIMAB", "avg_dose_mg": 476.0, "avg_administrations": 24}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £13,820
first_seen: 2018-12-05
last_seen: 2025-02-27
first_seen_parent: 2020-09-19
last_seen_parent: 2025-10-14
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 469.3, "avg_administrations": 21}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 19 times with a 4.6 weekly interval (87.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £24,817
first_seen: 2018-11-06
last_seen: 2025-08-09
first_seen_parent: 2020-06-02
last_seen_parent: 2025-01-17
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 363.9, "avg_administrations": 29}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 10 times with a 11.3 weekly interval (113.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Uveitis - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Uveitis - ADALIMUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £8,433
first_seen: 2020-09-22
last_seen: 2024-08-10
first_seen_parent: 2020-03-02
last_seen_parent: 2024-11-09
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 29 times with a 6.7 weekly interval (194.3 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 10 times with a 6.1 weekly interval (61.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 460.1, "avg_administrations": 25}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 239.4, "avg_administrations": 25}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Uveitis - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Uveitis - ADALIMUMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £10,113
first_seen: 2019-02-15
last_seen: 2025-05-18
first_seen_parent: 2019-06-10
last_seen_parent: 2024-12-21
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 25 times with a 5.8 weekly interval (145.0 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 12 times with a 9.4 weekly interval (112.8 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 180.8, "avg_administrations": 26}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 356.7, "avg_administrations": 14}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Uveitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £5,462
first_seen: 2018-01-03
last_seen: 2024-03-08
first_seen_parent: 2017-07-21
last_seen_parent: 2024-01-01
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 326.4, "avg_administrations": 19}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 22 times with a 7.0 weekly interval (154.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD - AFLIBERCEPT
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD - AFLIBERCEPT - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £7,655
first_seen: 2020-12-17
last_seen: 2025-10-31
first_seen_parent: 2020-12-04
last_seen_parent: 2025-07-07
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: AFLIBERCEPT|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 26 times with a 5.7 weekly interval (148.2 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 19 times with a 7.7 weekly interval (146.3 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 302.8, "avg_administrations": 17}, {"drug": "BARICITINIB", "avg_dose_mg": 270.6, "avg_administrations": 20}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD - AFLIBERCEPT
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD - AFLIBERCEPT - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £8,788
first_seen: 2021-01-01
last_seen: 2024-11-02
first_seen_parent: 2021-08-31
last_seen_parent: 2024-07-09
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: AFLIBERCEPT|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 26 times with a 7.0 weekly interval (182.0 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 5 times with a 6.7 weekly interval (33.5 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 343.6, "avg_administrations": 7}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 81.1, "avg_administrations": 4}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £16,957
first_seen: 2021-01-05
last_seen: 2025-08-05
first_seen_parent: 2018-07-11
last_seen_parent: 2025-09-22
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 96.9, "avg_administrations": 18}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 17 times with a 2.4 weekly interval (40.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £25,799
first_seen: 2020-05-14
last_seen: 2025-01-28
first_seen_parent: 2020-02-14
last_seen_parent: 2024-11-07
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 225.5, "avg_administrations": 27}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 16 times with a 10.4 weekly interval (166.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £5,674
first_seen: 2019-05-03
last_seen: 2024-11-09
first_seen_parent: 2020-02-25
last_seen_parent: 2025-02-21
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 373.9, "avg_administrations": 20}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 11 times with a 4.6 weekly interval (50.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB
labels: INFLIXIMAB
cost_pp_pa: £3,710
first_seen: 2022-01-23
last_seen: 2024-08-18
first_seen_parent: 2019-03-18
last_seen_parent: 2024-10-19
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB - INFLIXIMAB

average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 16 times with a 8.8 weekly interval (140.8 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 29 times with a 9.8 weekly interval (284.2 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 378.3, "avg_administrations": 28}, {"drug": "INFLIXIMAB", "avg_dose_mg": 478.8, "avg_administrations": 17}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £15,174
first_seen: 2018-10-01
last_seen: 2025-09-20
first_seen_parent: 2019-10-31
last_seen_parent: 2025-10-28
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 147.8, "avg_administrations": 25}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 6 times with a 11.2 weekly interval (67.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Atopic dermatitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £25,460
first_seen: 2019-09-29
last_seen: 2024-01-06
first_seen_parent: 2017-11-16
last_seen_parent: 2025-10-06
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 249.0, "avg_administrations": 26}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 5 times with a 6.6 weekly interval (33.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL - IBRUTINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL - IBRUTINIB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £20,137
first_seen: 2022-05-15
last_seen: 2024-02-25
first_seen_parent: 2021-06-18
last_seen_parent: 2024-03-10
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: IBRUTINIB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 23 times with a 8.1 weekly interval (186.3 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 23 times with a 8.4 weekly interval (193.2 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 416.9, "avg_administrations": 18}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 384.6, "avg_administrations": 29}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £22,108
first_seen: 2018-05-09
last_seen: 2024-04-21
first_seen_parent: 2020-03-01
last_seen_parent: 2025-04-21
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 80.9, "avg_administrations": 20}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 20 times with a 2.2 weekly interval (44.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Colorectal cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £13,784
first_seen: 2021-07-16
last_seen: 2025-09-25
first_seen_parent: 2019-10-12
last_seen_parent: 2025-02-08
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 348.7, "avg_administrations": 15}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 20 times with a 10.3 weekly interval (206.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £12,324
first_seen: 2018-05-10
last_seen: 2024-07-08
first_seen_parent: 2020-06-17
last_seen_parent: 2025-03-16
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 58.3, "avg_administrations": 13}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 16 times with a 4.1 weekly interval (65.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - ADALIMUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - ADALIMUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £15,698
first_seen: 2020-12-07
last_seen: 2024-06-26
first_seen_parent: 2018-04-19
last_seen_parent: 2024-02-16
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4 times with a 8.5 weekly interval (34.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 17 times with a 2.7 weekly interval (45.9 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 357.7, "avg_administrations": 18}, {"drug": "SECUKINUMAB", "avg_dose_mg": 493.6, "avg_administrations": 29}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £24,387
first_seen: 2018-12-12
last_seen: 2025-12-25
first_seen_parent: 2017-09-18
last_seen_parent: 2025-12-02
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 215.6, "avg_administrations": 25}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 16 times with a 9.4 weekly interval (150.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Diabetic macular oedema
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £23,474
first_seen: 2018-07-11
last_seen: 2025-03-26
first_seen_parent: 2017-11-27
last_seen_parent: 2024-09-14
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 347.7, "avg_administrations": 11}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 4 times with a 6.9 weekly interval (27.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £10,929
first_seen: 2022-05-13
last_seen: 2025-01-09
first_seen_parent: 2021-03-04
last_seen_parent: 2024-03-29
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOCILIZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 6 times with a 4.4 weekly interval (26.4 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 25 times with a 3.3 weekly interval (82.5 weeks total treatment length)

average_administered:
[{"drug": "TOCILIZUMAB", "avg_dose_mg": 370.6, "avg_administrations": 14}, {"drug": "INFLIXIMAB", "avg_dose_mg": 290.2, "avg_administrations": 29}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Giant cell arteritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £14,565
first_seen: 2021-12-11
last_seen: 2025-09-20
first_seen_parent: 2020-12-09
last_seen_parent: 2024-08-15
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 204.9, "avg_administrations": 9}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 12 times with a 8.8 weekly interval (105.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £8,482
first_seen: 2021-06-06
last_seen: 2025-01-05
first_seen_parent: 2018-03-16
last_seen_parent: 2025-08-22
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TRASTUZUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 23 times with a 7.2 weekly interval (165.6 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 23 times with a 7.8 weekly interval (179.4 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 245.2, "avg_administrations": 24}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 457.1, "avg_administrations": 19}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HER2+ breast cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £16,631
first_seen: 2020-07-12
last_seen: 2024-05-23
first_seen_parent: 2017-11-28
last_seen_parent: 2025-08-23
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 436.5, "avg_administrations": 6}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 26 times with a 3.9 weekly interval (101.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Mantle cell lymphoma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £2,553
first_seen: 2019-07-06
last_seen: 2024-06-11
first_seen_parent: 2018-01-17
last_seen_parent: 2024-07-11
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 300.9, "avg_administrations": 6}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 12 times with a 5.3 weekly interval (63.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Melanoma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £12,495
first_seen: 2020-12-07
last_seen: 2025-12-04
first_seen_parent: 2017-09-10
last_seen_parent: 2025-02-21
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 449.7, "avg_administrations": 29}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 15 times with a 7.6 weekly interval (114.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple myeloma - LENALIDOMIDE
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple myeloma - LENALIDOMIDE - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £3,687
first_seen: 2020-11-13
last_seen: 2024-04-27
first_seen_parent: 2018-10-28
last_seen_parent: 2025-05-15
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: LENALIDOMIDE|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 27 times with a 4.3 weekly interval (116.1 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 27 times with a 8.9 weekly interval (240.3 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 264.1, "avg_administrations": 9}, {"drug": "RITUXIMAB", "avg_dose_mg": 352.4, "avg_administrations": 18}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple myeloma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £10,387
first_seen: 2021-06-29
last_seen: 2024-08-17
first_seen_parent: 2019-05-31
last_seen_parent: 2025-03-26
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 100.4, "avg_administrations": 20}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 12 times with a 9.4 weekly interval (112.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £16,120
first_seen: 2021-05-26
last_seen: 2025-04-22
first_seen_parent: 2017-09-14
last_seen_parent: 2025-05-02
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 131.3, "avg_administrations": 20}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 9 times with a 10.8 weekly interval (97.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - NATALIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - NATALIZUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £6,837
first_seen: 2021-08-18
last_seen: 2025-02-19
first_seen_parent: 2019-02-04
last_seen_parent: 2025-04-18
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NATALIZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 23 times with a 3.0 weekly interval (69.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 12 times with a 3.7 weekly interval (44.4 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 331.6, "avg_administrations": 19}, {"drug": "TOFACITINIB", "avg_dose_mg": 232.2, "avg_administrations": 15}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - NATALIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - NATALIZUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £13,709
first_seen: 2019-01-20
last_seen: 2025-05-23
first_seen_parent: 2018-12-03
last_seen_parent: 2025-02-10
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NATALIZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 6 times with a 10.7 weekly interval (64.2 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 14 times with a 11.1 weekly interval (155.4 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 274.2, "avg_administrations": 15}, {"drug": "INFLIXIMAB", "avg_dose_mg": 424.2, "avg_administrations": 26}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £21,448
first_seen: 2019-03-15
last_seen: 2025-08-24
first_seen_parent: 2018-12-29
last_seen_parent: 2025-09-30
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 434.9, "avg_administrations": 25}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 5 times with a 8.9 weekly interval (44.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-Hodgkin lymphoma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £9,017
first_seen: 2018-10-14
last_seen: 2024-07-09
first_seen_parent: 2020-11-07
last_seen_parent: 2025-07-19
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 179.7, "avg_administrations": 8}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 21 times with a 5.2 weekly interval (109.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - PEMBROLIZUMAB
labels: LENALIDOMIDE
cost_pp_pa: £15,698
first_seen: 2020-07-04
last_seen: 2024-01-25
first_seen_parent: 2020-02-25
last_seen_parent: 2025-05-11
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: PEMBROLIZUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - PEMBROLIZUMAB - LENALIDOMIDE

average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 15 times with a 10.5 weekly interval (157.5 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 11 times with a 8.5 weekly interval (93.5 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 191.9, "avg_administrations": 23}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 118.7, "avg_administrations": 19}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - PEMBROLIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £12,953
first_seen: 2019-11-01
last_seen: 2025-07-24
first_seen_parent: 2019-04-17
last_seen_parent: 2024-05-21
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: PEMBROLIZUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - PEMBROLIZUMAB - OCRELIZUMAB

average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 20 times with a 3.8 weekly interval (76.0 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 15 times with a 6.9 weekly interval (103.5 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 330.3, "avg_administrations": 24}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 189.6, "avg_administrations": 5}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £23,260
first_seen: 2021-10-18
last_seen: 2024-09-16
first_seen_parent: 2018-08-03
last_seen_parent: 2024-01-23
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 433.4, "avg_administrations": 10}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 15 times with a 4.3 weekly interval (64.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £7,232
first_seen: 2019-09-16
last_seen: 2025-02-06
first_seen_parent: 2020-12-05
last_seen_parent: 2024-09-01
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 326.6, "avg_administrations": 13}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 14 times with a 3.0 weekly interval (42.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £7,775
first_seen: 2021-12-27
last_seen: 2025-10-10
first_seen_parent: 2020-02-02
last_seen_parent: 2024-09-01
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BEVACIZUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB - PEMBROLIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 13 times with a 8.6 weekly interval (111.8 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 19 times with a 2.1 weekly interval (39.9 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 426.2, "avg_administrations": 20}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 272.8, "avg_administrations": 5}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £9,385
first_seen: 2020-06-07
last_seen: 2025-10-08
first_seen_parent: 2020-06-06
last_seen_parent: 2024-07-30
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 468.8, "avg_administrations": 22}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 15 times with a 8.9 weekly interval (133.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £12,423
first_seen: 2019-10-16
last_seen: 2024-07-19
first_seen_parent: 2018-08-09
last_seen_parent: 2024-08-03
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 428.6, "avg_administrations": 29}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 15 times with a 3.9 weekly interval (58.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - SECUKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - SECUKINUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £12,201
first_seen: 2020-02-16
last_seen: 2024-05-23
first_seen_parent: 2018-03-03
last_seen_parent: 2024-03-27
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 10 times with a 9.1 weekly interval (91.0 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 4 times with a 3.1 weekly interval (12.4 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 371.5, "avg_administrations": 23}, {"drug": "IBRUTINIB", "avg_dose_mg": 73.6, "avg_administrations": 29}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - SECUKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - SECUKINUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £10,171
first_seen: 2020-09-12
last_seen: 2025-07-15
first_seen_parent: 2020-09-06
last_seen_parent: 2024-07-12
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 6 times with a 3.6 weekly interval (21.6 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 29 times with a 10.1 weekly interval (292.9 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 309.5, "avg_administrations": 14}, {"drug": "NIVOLUMAB", "avg_dose_mg": 55.5, "avg_administrations": 8}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £15,891
first_seen: 2020-08-27
last_seen: 2024-04-17
first_seen_parent: 2018-10-15
last_seen_parent: 2025-08-19
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 170.6, "avg_administrations": 11}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 12 times with a 11.7 weekly interval (140.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £17,945
first_seen: 2019-09-10
last_seen: 2025-02-24
first_seen_parent: 2020-12-20
last_seen_parent: 2025-07-07
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 415.5, "avg_administrations": 11}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 26 times with a 9.0 weekly interval (234.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £10,498
first_seen: 2020-04-30
last_seen: 2025-12-11
first_seen_parent: 2017-03-16
last_seen_parent: 2025-07-30
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 406.6, "avg_administrations": 7}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 22 times with a 4.1 weekly interval (90.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £14,399
first_seen: 2022-04-15
last_seen: 2025-12-01
first_seen_parent: 2020-12-05
last_seen_parent: 2025-05-10
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 23 times with a 10.3 weekly interval (236.9 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 4 times with a 2.2 weekly interval (8.8 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 279.9, "avg_administrations": 24}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 142.5, "avg_administrations": 28}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £8,550
first_seen: 2019-05-22
last_seen: 2024-12-12
first_seen_parent: 2019-07-31
last_seen_parent: 2024-09-28
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 6 times with a 5.7 weekly interval (34.2 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 9 times with a 4.5 weekly interval (40.5 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 446.8, "avg_administrations": 27}, {"drug": "BARICITINIB", "avg_dose_mg": 313.6, "avg_administrations": 18}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £20,122
first_seen: 2018-12-18
last_seen: 2024-12-06
first_seen_parent: 2020-08-09
last_seen_parent: 2025-03-15
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 244.0, "avg_administrations": 6}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 29 times with a 7.1 weekly interval (205.9 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £3,780
first_seen: 2018-04-21
last_seen: 2025-10-19
first_seen_parent: 2018-02-18
last_seen_parent: 2025-02-09
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 256.4, "avg_administrations": 28}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5 times with a 6.9 weekly interval (34.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £2,818
first_seen: 2018-06-17
last_seen: 2025-06-12
first_seen_parent: 2017-08-31
last_seen_parent: 2024-08-23
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 486.4, "avg_administrations": 28}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 20 times with a 3.9 weekly interval (78.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - BARICITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - BARICITINIB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £19,171
first_seen: 2021-12-22
last_seen: 2024-11-21
first_seen_parent: 2018-01-19
last_seen_parent: 2024-03-31
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BARICITINIB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 24 times with a 2.3 weekly interval (55.2 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 19 times with a 3.3 weekly interval (62.7 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 306.5, "avg_administrations": 15}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 90.9, "avg_administrations": 29}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - BARICITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - BARICITINIB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £12,852
first_seen: 2019-03-04
last_seen: 2025-06-16
first_seen_parent: 2018-11-12
last_seen_parent: 2025-12-23
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BARICITINIB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 22 times with a 10.2 weekly interval (224.4 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 28 times with a 7.9 weekly interval (221.2 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 213.3, "avg_administrations": 14}, {"drug": "ADALIMUMAB", "avg_dose_mg": 132.0, "avg_administrations": 27}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £13,203
first_seen: 2018-07-14
last_seen: 2025-02-14
first_seen_parent: 2018-06-28
last_seen_parent: 2025-07-21
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 245.8, "avg_administrations": 5}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 11 times with a 5.2 weekly interval (57.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £19,090
first_seen: 2018-12-11
last_seen: 2025-11-25
first_seen_parent: 2019-04-02
last_seen_parent: 2025-10-26
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 424.3, "avg_administrations": 25}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 28 times with a 2.3 weekly interval (64.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £22,476
first_seen: 2021-02-25
last_seen: 2024-05-21
first_seen_parent: 2020-10-02
last_seen_parent: 2025-02-21
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 76.0, "avg_administrations": 29}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 29 times with a 8.5 weekly interval (246.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £12,350
first_seen: 2018-12-26
last_seen: 2025-04-10
first_seen_parent: 2017-12-23
last_seen_parent: 2025-05-25
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 370.0, "avg_administrations": 4}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 23 times with a 3.5 weekly interval (80.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - TOFACITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - TOFACITINIB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £8,686
first_seen: 2021-06-20
last_seen: 2025-07-09
first_seen_parent: 2019-01-17
last_seen_parent: 2025-09-27
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOFACITINIB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 10 times with a 6.9 weekly interval (69.0 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 15 times with a 7.7 weekly interval (115.5 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 166.5, "avg_administrations": 5}, {"drug": "NIVOLUMAB", "avg_dose_mg": 345.5, "avg_administrations": 28}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £10,919
first_seen: 2021-07-26
last_seen: 2025-04-22
first_seen_parent: 2017-02-25
last_seen_parent: 2024-08-06
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 102.4, "avg_administrations": 21}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 29 times with a 4.7 weekly interval (136.3 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Uveitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £23,413
first_seen: 2021-11-11
last_seen: 2025-10-28
first_seen_parent: 2017-11-29
last_seen_parent: 2024-01-27
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 138.8, "avg_administrations": 20}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 23 times with a 7.4 weekly interval (170.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £14,734
first_seen: 2020-11-27
last_seen: 2024-04-01
first_seen_parent: 2019-04-21
last_seen_parent: 2024-09-10
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 87.1, "avg_administrations": 25}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 20 times with a 9.3 weekly interval (186.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £18,933
first_seen: 2019-01-31
last_seen: 2025-03-25
first_seen_parent: 2020-08-29
last_seen_parent: 2024-08-01
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 463.3, "avg_administrations": 26}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 5 times with a 10.6 weekly interval (53.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - ETANERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - ETANERCEPT - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £17,482
first_seen: 2019-06-11
last_seen: 2025-08-12
first_seen_parent: 2019-03-03
last_seen_parent: 2024-03-11
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 28 times with a 11.2 weekly interval (313.6 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 26 times with a 10.3 weekly interval (267.8 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 238.9, "avg_administrations": 11}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 291.2, "avg_administrations": 13}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - ETANERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - ETANERCEPT - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £8,558
first_seen: 2022-07-10
last_seen: 2025-03-23
first_seen_parent: 2019-04-07
last_seen_parent: 2025-02-02
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 10 times with a 5.1 weekly interval (51.0 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 27 times with a 9.5 weekly interval (256.5 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 197.0, "avg_administrations": 17}, {"drug": "IBRUTINIB", "avg_dose_mg": 419.6, "avg_administrations": 6}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £11,574
first_seen: 2020-10-26
last_seen: 2024-07-17
first_seen_parent: 2017-08-26
last_seen_parent: 2025-03-11
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 254.9, "avg_administrations": 6}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 29 times with a 9.3 weekly interval (269.7 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £28,896
first_seen: 2020-09-24
last_seen: 2025-03-07
first_seen_parent: 2018-03-12
last_seen_parent: 2025-04-05
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 107.1, "avg_administrations": 7}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 25 times with a 7.3 weekly interval (182.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Atopic dermatitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £21,697
first_seen: 2018-03-28
last_seen: 2024-06-23
first_seen_parent: 2020-11-30
last_seen_parent: 2024-09-11
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 263.7, "avg_administrations": 5}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 5 times with a 9.1 weekly interval (45.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £25,157
first_seen: 2020-11-02
last_seen: 2025-01-20
first_seen_parent: 2020-07-04
last_seen_parent: 2025-11-18
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 155.6, "avg_administrations": 21}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 20 times with a 4.9 weekly interval (98.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £23,173
first_seen: 2019-07-06
last_seen: 2025-05-13
first_seen_parent: 2019-01-30
last_seen_parent: 2024-12-19
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 358.9, "avg_administrations": 13}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 23 times with a 10.5 weekly interval (241.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Colorectal cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £7,256
first_seen: 2018-03-31
last_seen: 2024-03-11
first_seen_parent: 2019-08-19
last_seen_parent: 2024-12-03
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 96.4, "avg_administrations": 8}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 4 times with a 8.2 weekly interval (32.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £3,575
first_seen: 2019-10-02
last_seen: 2024-01-22
first_seen_parent: 2020-02-05
last_seen_parent: 2025-09-12
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 320.2, "avg_administrations": 7}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 15 times with a 2.4 weekly interval (36.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - VEDOLIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - VEDOLIZUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £22,391
first_seen: 2022-08-14
last_seen: 2025-01-02
first_seen_parent: 2019-10-11
last_seen_parent: 2025-02-22
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: VEDOLIZUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 11 times with a 7.4 weekly interval (81.4 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 23 times with a 3.0 weekly interval (69.0 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 262.3, "avg_administrations": 18}, {"drug": "USTEKINUMAB", "avg_dose_mg": 494.4, "avg_administrations": 22}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - VEDOLIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - VEDOLIZUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £19,973
first_seen: 2021-10-03
last_seen: 2024-02-04
first_seen_parent: 2018-04-05
last_seen_parent: 2024-02-06
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: VEDOLIZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 8 times with a 3.9 weekly interval (31.2 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 29 times with a 4.7 weekly interval (136.3 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 288.1, "avg_administrations": 8}, {"drug": "TOFACITINIB", "avg_dose_mg": 77.2, "avg_administrations": 5}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £23,249
first_seen: 2021-05-14
last_seen: 2024-01-06
first_seen_parent: 2019-04-15
last_seen_parent: 2024-04-08
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 327.5, "avg_administrations": 7}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 16 times with a 3.9 weekly interval (62.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £22,021
first_seen: 2021-07-01
last_seen: 2024-01-27
first_seen_parent: 2018-02-05
last_seen_parent: 2024-04-13
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 443.3, "avg_administrations": 12}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 30 times with a 10.0 weekly interval (300.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - ADALIMUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - ADALIMUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £6,456
first_seen: 2021-05-19
last_seen: 2025-04-18
first_seen_parent: 2019-01-10
last_seen_parent: 2024-08-02
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 16 times with a 8.2 weekly interval (131.2 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 19 times with a 9.9 weekly interval (188.1 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 89.9, "avg_administrations": 6}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 78.3, "avg_administrations": 12}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - ADALIMUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - ADALIMUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £13,799
first_seen: 2019-05-19
last_seen: 2025-01-05
first_seen_parent: 2021-10-06
last_seen_parent: 2025-06-09
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 25 times with a 2.8 weekly interval (70.0 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 22 times with a 6.4 weekly interval (140.8 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 155.7, "avg_administrations": 20}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 326.9, "avg_administrations": 12}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £20,931
first_seen: 2018-03-28
last_seen: 2024-07-21
first_seen_parent: 2019-06-15
last_seen_parent: 2025-04-28
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 208.1, "avg_administrations": 9}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 19 times with a 6.7 weekly interval (127.3 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Diabetic macular oedema
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £21,160
first_seen: 2021-12-01
last_seen: 2024-03-16
first_seen_parent: 2019-04-17
last_seen_parent: 2024-05-06
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 431.9, "avg_administrations": 22}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 12 times with a 2.2 weekly interval (26.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Giant cell arteritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £13,032
first_seen: 2020-06-18
last_seen: 2024-12-08
first_seen_parent: 2020-10-26
last_seen_parent: 2024-02-13
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 59.6, "avg_administrations": 20}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 29 times with a 8.5 weekly interval (246.5 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HER2+ breast cancer - TRASTUZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HER2+ breast cancer - TRASTUZUMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £15,827
first_seen: 2019-06-13
last_seen: 2025-01-21
first_seen_parent: 2020-05-03
last_seen_parent: 2025-12-28
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TRASTUZUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 18 times with a 9.3 weekly interval (167.4 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 6 times with a 5.8 weekly interval (34.8 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 402.6, "avg_administrations": 27}, {"drug": "BARICITINIB", "avg_dose_mg": 414.1, "avg_administrations": 25}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HER2+ breast cancer - TRASTUZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HER2+ breast cancer - TRASTUZUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £10,520
first_seen: 2020-09-26
last_seen: 2024-04-21
first_seen_parent: 2018-01-01
last_seen_parent: 2025-05-12
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TRASTUZUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 6 times with a 7.9 weekly interval (47.4 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 7 times with a 2.4 weekly interval (16.8 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 196.4, "avg_administrations": 24}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 89.5, "avg_administrations": 13}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HER2+ breast cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £14,390
first_seen: 2019-07-31
last_seen: 2024-11-29
first_seen_parent: 2019-10-16
last_seen_parent: 2024-02-23
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 369.7, "avg_administrations": 10}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 6 times with a 6.7 weekly interval (40.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Mantle cell lymphoma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £21,227
first_seen: 2021-03-14
last_seen: 2024-10-24
first_seen_parent: 2018-01-30
last_seen_parent: 2025-05-28
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 467.6, "avg_administrations": 27}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 24 times with a 4.7 weekly interval (112.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Melanoma - PEMBROLIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Melanoma - PEMBROLIZUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £10,743
first_seen: 2021-11-08
last_seen: 2024-05-01
first_seen_parent: 2020-11-13
last_seen_parent: 2025-04-02
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: PEMBROLIZUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 19 times with a 10.4 weekly interval (197.6 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 28 times with a 3.8 weekly interval (106.4 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 270.6, "avg_administrations": 25}, {"drug": "IBRUTINIB", "avg_dose_mg": 190.5, "avg_administrations": 23}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Melanoma - PEMBROLIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Melanoma - PEMBROLIZUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £13,971
first_seen: 2019-02-22
last_seen: 2024-02-07
first_seen_parent: 2021-02-07
last_seen_parent: 2025-05-31
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: PEMBROLIZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 16 times with a 7.6 weekly interval (121.6 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 28 times with a 11.2 weekly interval (313.6 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 289.8, "avg_administrations": 21}, {"drug": "TOFACITINIB", "avg_dose_mg": 104.7, "avg_administrations": 27}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Melanoma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £12,128
first_seen: 2020-12-04
last_seen: 2025-10-08
first_seen_parent: 2020-03-23
last_seen_parent: 2025-07-29
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 340.5, "avg_administrations": 7}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 4 times with a 6.3 weekly interval (25.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple myeloma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £9,887
first_seen: 2020-06-29
last_seen: 2024-02-06
first_seen_parent: 2020-06-14
last_seen_parent: 2024-07-02
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 256.9, "avg_administrations": 9}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 4 times with a 3.3 weekly interval (13.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £17,853
first_seen: 2021-04-30
last_seen: 2024-12-06
first_seen_parent: 2020-11-19
last_seen_parent: 2025-11-20
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 376.5, "avg_administrations": 25}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 23 times with a 9.8 weekly interval (225.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £8,230
first_seen: 2019-11-28
last_seen: 2024-02-02
first_seen_parent: 2018-10-28
last_seen_parent: 2024-06-21
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 440.1, "avg_administrations": 19}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 29 times with a 6.8 weekly interval (197.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-Hodgkin lymphoma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £12,394
first_seen: 2020-09-02
last_seen: 2025-09-16
first_seen_parent: 2020-04-10
last_seen_parent: 2024-09-23
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 391.3, "avg_administrations": 30}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 6 times with a 11.7 weekly interval (70.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £14,022
first_seen: 2020-01-06
last_seen: 2024-08-20
first_seen_parent: 2018-03-10
last_seen_parent: 2024-11-17
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 254.6, "avg_administrations": 10}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 11 times with a 7.7 weekly interval (84.7 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £6,616
first_seen: 2021-03-30
last_seen: 2025-07-21
first_seen_parent: 2018-09-08
last_seen_parent: 2025-07-12
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 71.7, "avg_administrations": 22}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 13 times with a 7.8 weekly interval (101.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £17,248
first_seen: 2020-04-17
last_seen: 2024-02-05
first_seen_parent: 2021-09-24
last_seen_parent: 2025-03-27
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BEVACIZUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - BEVACIZUMAB - NATALIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 27 times with a 5.7 weekly interval (153.9 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 15 times with a 11.8 weekly interval (177.0 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 300.7, "avg_administrations": 15}, {"drug": "NATALIZUMAB", "avg_dose_mg": 402.5, "avg_administrations": 28}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: LENALIDOMIDE
cost_pp_pa: £7,661
first_seen: 2020-12-14
last_seen: 2025-04-25
first_seen_parent: 2020-02-29
last_seen_parent: 2024-04-13
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BEVACIZUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - BEVACIZUMAB - LENALIDOMIDE

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 20 times with a 3.5 weekly interval (70.0 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 12 times with a 6.6 weekly interval (79.2 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 421.2, "avg_administrations": 12}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 491.6, "avg_administrations": 18}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £25,142
first_seen: 2020-03-14
last_seen: 2024-07-18
first_seen_parent: 2020-11-16
last_seen_parent: 2024-02-29
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 404.9, "avg_administrations": 28}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 20 times with a 9.6 weekly interval (192.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £23,464
first_seen: 2021-08-25
last_seen: 2025-07-03
first_seen_parent: 2017-07-01
last_seen_parent: 2025-09-27
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 78.4, "avg_administrations": 9}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 17 times with a 4.1 weekly interval (69.7 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £24,401
first_seen: 2018-08-14
last_seen: 2024-03-17
first_seen_parent: 2018-10-25
last_seen_parent: 2025-04-23
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 192.7, "avg_administrations": 28}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 30 times with a 3.4 weekly interval (102.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £7,782
first_seen: 2020-05-08
last_seen: 2024-12-09
first_seen_parent: 2020-08-30
last_seen_parent: 2024-12-13
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 208.3, "avg_administrations": 25}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 4 times with a 8.9 weekly interval (35.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis - ETANERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis - ETANERCEPT - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £10,011
first_seen: 2021-11-24
last_seen: 2024-08-19
first_seen_parent: 2019-06-06
last_seen_parent: 2024-07-19
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 12 times with a 10.4 weekly interval (124.8 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 27 times with a 8.8 weekly interval (237.6 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 378.7, "avg_administrations": 26}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 168.9, "avg_administrations": 22}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis - ETANERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis - ETANERCEPT - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £11,801
first_seen: 2020-11-22
last_seen: 2025-09-10
first_seen_parent: 2020-08-07
last_seen_parent: 2025-06-24
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 6 times with a 6.1 weekly interval (36.6 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 4 times with a 10.5 weekly interval (42.0 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 61.8, "avg_administrations": 23}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 91.3, "avg_administrations": 7}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £3,660
first_seen: 2020-01-03
last_seen: 2024-02-09
first_seen_parent: 2019-10-03
last_seen_parent: 2025-11-14
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 414.5, "avg_administrations": 14}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 23 times with a 2.2 weekly interval (50.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £4,571
first_seen: 2020-07-26
last_seen: 2024-07-19
first_seen_parent: 2019-01-21
last_seen_parent: 2025-08-10
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 68.6, "avg_administrations": 18}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 21 times with a 4.8 weekly interval (100.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Renal cell carcinoma - NIVOLUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Renal cell carcinoma - NIVOLUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £18,713
first_seen: 2022-01-24
last_seen: 2024-08-03
first_seen_parent: 2020-01-02
last_seen_parent: 2024-06-16
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NIVOLUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 30 times with a 11.5 weekly interval (345.0 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 5 times with a 8.1 weekly interval (40.5 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 58.5, "avg_administrations": 19}, {"drug": "IBRUTINIB", "avg_dose_mg": 256.7, "avg_administrations": 18}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Renal cell carcinoma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £15,314
first_seen: 2020-06-24
last_seen: 2025-04-02
first_seen_parent: 2020-10-27
last_seen_parent: 2024-04-03
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 236.9, "avg_administrations": 23}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 27 times with a 5.2 weekly interval (140.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £11,799
first_seen: 2020-12-05
last_seen: 2024-07-26
first_seen_parent: 2018-06-17
last_seen_parent: 2024-04-09
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 308.5, "avg_administrations": 11}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 11 times with a 7.4 weekly interval (81.4 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £7,915
first_seen: 2019-04-24
last_seen: 2025-07-25
first_seen_parent: 2020-09-19
last_seen_parent: 2025-11-07
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 401.9, "avg_administrations": 24}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 21 times with a 3.9 weekly interval (81.9 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £15,690
first_seen: 2021-08-12
last_seen: 2024-04-17
first_seen_parent: 2018-07-16
last_seen_parent: 2024-03-28
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 163.8, "avg_administrations": 4}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 18 times with a 8.0 weekly interval (144.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £19,144
first_seen: 2020-09-05
last_seen: 2025-07-29
first_seen_parent: 2019-08-02
last_seen_parent: 2025-02-01
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 463.9, "avg_administrations": 9}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 25 times with a 4.8 weekly interval (120.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £3,874
first_seen: 2018-01-08
last_seen: 2025-02-18
first_seen_parent: 2019-02-25
last_seen_parent: 2024-03-15
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 478.5, "avg_administrations": 14}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 24 times with a 9.2 weekly interval (220.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - INFLIXIMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - INFLIXIMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £12,655
first_seen: 2019-09-26
last_seen: 2024-11-02
first_seen_parent: 2020-09-22
last_seen_parent: 2025-09-01
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: INFLIXIMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 18 times with a 8.5 weekly interval (153.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 25 times with a 4.6 weekly interval (115.0 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 229.9, "avg_administrations": 23}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 440.4, "avg_administrations": 25}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - INFLIXIMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - INFLIXIMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £17,045
first_seen: 2020-08-17
last_seen: 2025-06-08
first_seen_parent: 2020-08-06
last_seen_parent: 2024-08-16
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: INFLIXIMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 15 times with a 10.4 weekly interval (156.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 13 times with a 11.2 weekly interval (145.6 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 51.4, "avg_administrations": 11}, {"drug": "SECUKINUMAB", "avg_dose_mg": 323.1, "avg_administrations": 23}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £12,160
first_seen: 2020-10-08
last_seen: 2024-06-18
first_seen_parent: 2020-11-29
last_seen_parent: 2025-10-06
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 410.1, "avg_administrations": 17}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 12 times with a 10.9 weekly interval (130.8 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £8,480
first_seen: 2020-03-03
last_seen: 2024-06-20
first_seen_parent: 2018-03-16
last_seen_parent: 2024-12-31
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 270.1, "avg_administrations": 19}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 16 times with a 2.1 weekly interval (33.6 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £10,788
first_seen: 2020-08-30
last_seen: 2025-08-22
first_seen_parent: 2018-04-08
last_seen_parent: 2025-02-26
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 357.1, "avg_administrations": 21}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 5 times with a 3.2 weekly interval (16.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Uveitis - ADALIMUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Uveitis - ADALIMUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £18,483
first_seen: 2020-12-21
last_seen: 2024-01-20
first_seen_parent: 2020-03-29
last_seen_parent: 2024-11-11
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 23 times with a 6.1 weekly interval (140.3 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 27 times with a 10.2 weekly interval (275.4 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 384.4, "avg_administrations": 27}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 398.6, "avg_administrations": 10}]


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Uveitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £16,791
first_seen: 2021-08-13
last_seen: 2025-12-02
first_seen_parent: 2019-05-07
last_seen_parent: 2025-11-14
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 75.0, "avg_administrations": 8}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 30 times with a 11.5 weekly interval (345.0 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £19,513
first_seen: 2020-11-25
last_seen: 2025-06-24
first_seen_parent: 2020-07-09
last_seen_parent: 2024-08-05
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 313.5, "avg_administrations": 16}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 6 times with a 7.7 weekly interval (46.2 weeks total treatment length)


date_filter_id: 1yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £13,633
first_seen: 2019-07-20
last_seen: 2025-09-08
first_seen_parent: 2019-03-07
last_seen_parent: 2025-08-04
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 139.6, "avg_administrations": 8}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 29 times with a 3.7 weekly interval (107.3 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £19,938
first_seen: 2018-06-10
last_seen: 2025-12-21
first_seen_parent: 2019-03-04
last_seen_parent: 2024-12-03
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 434.0, "avg_administrations": 20}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 9 times with a 7.8 weekly interval (70.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £11,833
first_seen: 2020-01-23
last_seen: 2025-02-01
first_seen_parent: 2020-05-25
last_seen_parent: 2024-01-06
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 412.8, "avg_administrations": 5}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 23 times with a 11.0 weekly interval (253.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - USTEKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - USTEKINUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £17,212
first_seen: 2021-02-10
last_seen: 2025-01-21
first_seen_parent: 2018-05-26
last_seen_parent: 2025-08-30
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 11 times with a 6.8 weekly interval (74.8 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 16 times with a 3.3 weekly interval (52.8 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 247.3, "avg_administrations": 27}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 345.3, "avg_administrations": 18}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - USTEKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - USTEKINUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £5,072
first_seen: 2021-09-09
last_seen: 2025-07-27
first_seen_parent: 2020-07-24
last_seen_parent: 2024-08-14
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 13 times with a 8.7 weekly interval (113.1 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 25 times with a 5.2 weekly interval (130.0 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 53.2, "avg_administrations": 5}, {"drug": "RITUXIMAB", "avg_dose_mg": 391.2, "avg_administrations": 24}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £14,218
first_seen: 2019-12-27
last_seen: 2024-05-19
first_seen_parent: 2020-03-04
last_seen_parent: 2025-07-13
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 352.1, "avg_administrations": 29}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 22 times with a 4.3 weekly interval (94.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - USTEKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - USTEKINUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £8,140
first_seen: 2022-04-17
last_seen: 2025-03-07
first_seen_parent: 2018-07-08
last_seen_parent: 2025-05-19
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 10 times with a 10.2 weekly interval (102.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 23 times with a 8.9 weekly interval (204.7 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 69.3, "avg_administrations": 26}, {"drug": "ETANERCEPT", "avg_dose_mg": 258.1, "avg_administrations": 24}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £3,720
first_seen: 2020-02-27
last_seen: 2024-02-16
first_seen_parent: 2017-09-15
last_seen_parent: 2025-10-10
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 195.7, "avg_administrations": 22}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 12 times with a 6.9 weekly interval (82.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £9,497
first_seen: 2021-05-16
last_seen: 2024-04-01
first_seen_parent: 2017-01-18
last_seen_parent: 2025-04-08
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 178.3, "avg_administrations": 24}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 10 times with a 6.4 weekly interval (64.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - INFLIXIMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - INFLIXIMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £11,836
first_seen: 2019-07-08
last_seen: 2024-09-16
first_seen_parent: 2020-11-19
last_seen_parent: 2025-11-04
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 6 times with a 5.4 weekly interval (32.4 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 11 times with a 7.6 weekly interval (83.6 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 357.8, "avg_administrations": 5}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 160.0, "avg_administrations": 4}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - INFLIXIMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - INFLIXIMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £16,297
first_seen: 2021-01-29
last_seen: 2025-07-01
first_seen_parent: 2020-09-24
last_seen_parent: 2025-05-04
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 7 times with a 5.0 weekly interval (35.0 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 25 times with a 5.7 weekly interval (142.5 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 282.5, "avg_administrations": 8}, {"drug": "NATALIZUMAB", "avg_dose_mg": 297.1, "avg_administrations": 14}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £12,815
first_seen: 2021-12-02
last_seen: 2024-05-26
first_seen_parent: 2020-06-13
last_seen_parent: 2025-12-08
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 136.0, "avg_administrations": 21}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 25 times with a 4.9 weekly interval (122.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - TOFACITINIB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - TOFACITINIB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £8,939
first_seen: 2020-03-30
last_seen: 2024-03-21
first_seen_parent: 2020-07-08
last_seen_parent: 2025-09-09
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 6 times with a 10.0 weekly interval (60.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 20 times with a 7.5 weekly interval (150.0 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 247.6, "avg_administrations": 24}, {"drug": "ETANERCEPT", "avg_dose_mg": 138.7, "avg_administrations": 20}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £4,679
first_seen: 2021-11-11
last_seen: 2024-07-30
first_seen_parent: 2020-04-12
last_seen_parent: 2025-03-19
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 392.9, "avg_administrations": 27}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 5 times with a 6.4 weekly interval (32.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £20,106
first_seen: 2018-08-17
last_seen: 2024-12-21
first_seen_parent: 2019-10-21
last_seen_parent: 2025-10-22
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 236.4, "avg_administrations": 8}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 14 times with a 4.5 weekly interval (63.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £11,278
first_seen: 2021-01-13
last_seen: 2025-08-22
first_seen_parent: 2017-09-25
last_seen_parent: 2025-09-03
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 229.2, "avg_administrations": 18}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 4 times with a 4.0 weekly interval (16.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £18,762
first_seen: 2020-09-10
last_seen: 2024-01-14
first_seen_parent: 2018-06-09
last_seen_parent: 2024-03-10
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 403.8, "avg_administrations": 12}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 22 times with a 11.1 weekly interval (244.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £24,261
first_seen: 2019-12-23
last_seen: 2025-10-22
first_seen_parent: 2019-10-23
last_seen_parent: 2025-08-09
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 402.9, "avg_administrations": 27}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 30 times with a 5.0 weekly interval (150.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - OCRELIZUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £6,339
first_seen: 2020-05-05
last_seen: 2025-04-27
first_seen_parent: 2021-04-21
last_seen_parent: 2024-08-21
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 11 times with a 10.6 weekly interval (116.6 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 13 times with a 8.2 weekly interval (106.6 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 59.8, "avg_administrations": 18}, {"drug": "ETANERCEPT", "avg_dose_mg": 400.9, "avg_administrations": 7}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £16,093
first_seen: 2019-03-30
last_seen: 2024-12-15
first_seen_parent: 2017-01-10
last_seen_parent: 2025-08-23
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 402.8, "avg_administrations": 4}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 4 times with a 3.5 weekly interval (14.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - NATALIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - NATALIZUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £6,840
first_seen: 2020-06-16
last_seen: 2024-10-06
first_seen_parent: 2021-02-14
last_seen_parent: 2024-08-11
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 9 times with a 9.4 weekly interval (84.6 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 19 times with a 10.0 weekly interval (190.0 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 389.0, "avg_administrations": 22}, {"drug": "USTEKINUMAB", "avg_dose_mg": 261.4, "avg_administrations": 5}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - NATALIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - NATALIZUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £18,807
first_seen: 2019-07-15
last_seen: 2025-12-17
first_seen_parent: 2021-11-03
last_seen_parent: 2024-11-10
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 7 times with a 4.8 weekly interval (33.6 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 18 times with a 10.4 weekly interval (187.2 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 376.0, "avg_administrations": 28}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 391.7, "avg_administrations": 11}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £8,134
first_seen: 2021-08-25
last_seen: 2024-01-17
first_seen_parent: 2019-08-28
last_seen_parent: 2025-09-04
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 223.0, "avg_administrations": 10}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 30 times with a 5.7 weekly interval (171.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - TRASTUZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - TRASTUZUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £16,851
first_seen: 2020-04-11
last_seen: 2025-10-30
first_seen_parent: 2020-09-05
last_seen_parent: 2025-09-07
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 22 times with a 4.4 weekly interval (96.8 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 17 times with a 2.5 weekly interval (42.5 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 107.0, "avg_administrations": 10}, {"drug": "IBRUTINIB", "avg_dose_mg": 205.7, "avg_administrations": 7}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - TRASTUZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - TRASTUZUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £19,940
first_seen: 2019-01-23
last_seen: 2024-09-23
first_seen_parent: 2020-06-15
last_seen_parent: 2024-04-23
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 4 times with a 3.8 weekly interval (15.2 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 25 times with a 5.7 weekly interval (142.5 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 86.9, "avg_administrations": 13}, {"drug": "TOFACITINIB", "avg_dose_mg": 459.5, "avg_administrations": 28}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £20,842
first_seen: 2020-09-05
last_seen: 2025-09-20
first_seen_parent: 2017-11-04
last_seen_parent: 2024-02-16
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 498.8, "avg_administrations": 29}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 11 times with a 10.8 weekly interval (118.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £6,825
first_seen: 2021-10-22
last_seen: 2024-02-12
first_seen_parent: 2018-09-14
last_seen_parent: 2025-03-20
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 486.0, "avg_administrations": 10}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 18 times with a 9.6 weekly interval (172.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - PEMBROLIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - PEMBROLIZUMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £10,123
first_seen: 2019-04-25
last_seen: 2025-04-27
first_seen_parent: 2021-02-25
last_seen_parent: 2025-09-10
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 18 times with a 7.4 weekly interval (133.2 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 10 times with a 10.8 weekly interval (108.0 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 493.5, "avg_administrations": 5}, {"drug": "BARICITINIB", "avg_dose_mg": 207.9, "avg_administrations": 28}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - PEMBROLIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - PEMBROLIZUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £8,374
first_seen: 2022-10-15
last_seen: 2024-12-27
first_seen_parent: 2021-11-19
last_seen_parent: 2024-03-09
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 24 times with a 2.1 weekly interval (50.4 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 28 times with a 6.2 weekly interval (173.6 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 412.7, "avg_administrations": 10}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 166.4, "avg_administrations": 13}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £13,504
first_seen: 2019-04-21
last_seen: 2025-02-14
first_seen_parent: 2017-01-03
last_seen_parent: 2025-03-01
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 339.8, "avg_administrations": 23}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 4 times with a 10.3 weekly interval (41.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £24,047
first_seen: 2018-09-16
last_seen: 2025-12-07
first_seen_parent: 2018-05-31
last_seen_parent: 2025-07-26
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 177.3, "avg_administrations": 13}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 9 times with a 6.5 weekly interval (58.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £21,761
first_seen: 2018-12-04
last_seen: 2024-08-29
first_seen_parent: 2019-03-03
last_seen_parent: 2025-04-20
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 91.6, "avg_administrations": 25}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10 times with a 6.6 weekly interval (66.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £4,619
first_seen: 2019-07-07
last_seen: 2025-10-01
first_seen_parent: 2017-02-01
last_seen_parent: 2024-06-23
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 218.9, "avg_administrations": 20}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 25 times with a 8.6 weekly interval (215.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - RANIBIZUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £16,121
first_seen: 2022-10-01
last_seen: 2025-11-01
first_seen_parent: 2021-05-19
last_seen_parent: 2024-11-22
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 21 times with a 5.3 weekly interval (111.3 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 24 times with a 6.0 weekly interval (144.0 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 82.5, "avg_administrations": 12}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 142.9, "avg_administrations": 16}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - RANIBIZUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £13,261
first_seen: 2019-04-01
last_seen: 2025-03-30
first_seen_parent: 2021-06-23
last_seen_parent: 2025-09-27
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 24 times with a 5.4 weekly interval (129.6 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 23 times with a 7.6 weekly interval (174.8 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 87.4, "avg_administrations": 17}, {"drug": "NATALIZUMAB", "avg_dose_mg": 402.0, "avg_administrations": 29}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £9,646
first_seen: 2019-12-05
last_seen: 2024-07-09
first_seen_parent: 2020-05-02
last_seen_parent: 2024-01-15
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 181.3, "avg_administrations": 10}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 22 times with a 9.7 weekly interval (213.4 weeks total treatment length)


